norgestrel has been researched along with levonorgestrel in 652 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 474 (72.70) | 18.7374 |
| 1990's | 136 (20.86) | 18.2507 |
| 2000's | 25 (3.83) | 29.6817 |
| 2010's | 14 (2.15) | 24.3611 |
| 2020's | 3 (0.46) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, B | 1 |
| Dain, MP; Janaud, A; Rouffy, J; Upmalis, D | 1 |
| Chapdelaine, A; London, RS; Olson, W; Smith, J; Upmalis, D | 1 |
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Fakeye, O | 1 |
| Brandstädt, A; Carol, W; Jäger, R; Kasch, R; Klinger, G | 1 |
| Carlier, PG; Fradin, EA; Gilles, RG; Rorive, GL; Vaesen, F | 1 |
| Belsey, EM; Croxtall, JD; d'Arcangues, C; Elder, MG; Patel, L; Sullivan, MH; White, JO | 1 |
| Ellingson, AB; Spellacy, WN; Tsibris, JC | 2 |
| Chen, GS; Wang, JG; Wang, Y; Zhong, JP; Zhou, RR | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Csemiczky, G; Landgren, BM | 1 |
| Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
| Christiansen, C; Marslew, U; Riis, B | 1 |
| Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
| Barlow, DH; Rees, MC | 1 |
| Bopp, BL; Fielding, M; Mishell, DR; Shoupe, D | 1 |
| Allonen, H; Luukkainen, T; Toivonen, J | 1 |
| Nightingale, SL | 1 |
| Friend, DR | 1 |
| Andersch, B; Andersson, K; Milsom, I; Rybo, G | 1 |
| Horenstein, J; Lacarra, M; Medearis, A; Mishell, DR; Shoupe, D | 1 |
| Christiansen, C; Haarbo, J; Leth-Espensen, P; Stender, S | 1 |
| Sivin, I | 1 |
| Meyboom, RH | 1 |
| Goodson, P; Hardy, E | 1 |
| Elder, MG; Elstein, M; Lawson, JP; Nuttall, ID | 1 |
| Huggins, GR; Wentz, AC | 1 |
| Flattum-Riemers, J | 1 |
| Croxatto, HB; Díaz, S; Sivin, I | 1 |
| Luukkainen, T | 1 |
| Fotherby, K | 4 |
| Alvarez-Sanchez, F; Brache, V; Cochon, L; Faundes, A; Tejada, AS | 2 |
| Aznar Ramos, R; Lara Ricalde, R; Lozano Baldera, M; Reynoso Ron, L | 2 |
| Alvarez-Sanchez, F; Brache, V; Faundes, A; Segal, SJ; Tuohimaa, P; Vilja, P | 1 |
| Back, DJ; Mant, T; Martin, C; Millar, E; Morrison, P; Orme, M; Tjia, J | 1 |
| Belsey, EM; Brosens, I; Cornillie, F; d'Arcangues, C; Elder, M; Hourihan, H; Johannisson, E; Sheppard, B; White, J | 1 |
| Belsey, EM; Brosens, IA; Hourihan, HM; Sheppard, BL | 1 |
| Baudhuin, P; Belsey, EM; Brosens, I; Cornillie, F; Courtoy, PJ; Marbaix, E | 1 |
| Christiansen, C; Haarbo, J; Hansen, BF | 1 |
| Tang, DC; Wu, XR | 1 |
| Bala, Y; Dhall, GI; Majumdar, S | 1 |
| Alvarez-Sanchez, F; Brache, V; Faúndes, A; Jimenez, E; Tejada, AS | 1 |
| De Souza, TR; Goodson, P; Hardy, E; Rodriguez, CM | 1 |
| Darney, PD | 1 |
| Wolley, RJ | 1 |
| Konje, JC; Ladipo, OA; Otolorin, EO | 1 |
| Ho, PC; Kwan, MS; Liu, WT | 1 |
| Otubu, JA; Towobola, OA; Uguru, VE | 1 |
| Chen, HC; Chow, LP; Du, MK; Zheng, HM | 1 |
| Ratnam, SS; Singh, K; Viegas, OA | 10 |
| Grubb, GS; Klavon, SL | 1 |
| Chiang, ST; Lobo, RA; Stanczyk, FZ; Woutersz, TB | 1 |
| Andrade, AT; Cuadros, A; Dhall, GI; Ji, G; Khan, T; Koetsawang, S; Kononova, ES; Krishna, U; Rodriquez la Puenta, J; Wyss, R | 3 |
| Andrade, AT; Cuadros, A; Dhall, GI; Ji, G; Khan, T; Koetsawang, S; Konova, ES; Krishna, U; Rodriquez la Puenta, J; Wyss, R | 1 |
| Hamerlynck, JV | 1 |
| Bleker, OP; Braat, DD; Hateboer, N; Kroes, H | 1 |
| Bull, CA; Houghton, CR; Langlands, AO; McKay, MJ | 1 |
| Allonen, H; Gao, J; Luukkainen, T; Sun, BL; Wang, SL; Wu, SC | 1 |
| Fotherby, K; He, CH; Liao, DL; Matlin, SA; Shi, YE; Van Look, PF; Vince, PM; Xu, JQ; Zhu, YH | 1 |
| Hager, SR; Kalkhoff, RK | 1 |
| Maree, J; Meyer, B; Müller, F; Wessels, P | 1 |
| Lähteenmäki, P; Luukkainen, T; Toivonen, J | 1 |
| Aedo, AR; Dada, O; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Achthoven, L; Janssen, J; van Manen, S | 1 |
| Johansson, E; Odlind, V; Olsson, SE | 2 |
| Angel de Toro, LA; Lavarello, AC; Roncales Mateo, JM; Sagasta, CL; Salas Diaz, R; Wiemeyer, JC | 1 |
| Bakos, O; Barbosa, I; Johansson, ED; Odlind, V; Olsson, SE | 1 |
| Belhadj, H; Croxatto, HB; Díaz, S; Pavez, M; Sivin, I; Stern, J | 1 |
| Andersson, JK; Rybo, G | 1 |
| Wang, SL | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Buckshee, K; Kumar, S; Saraya, L | 1 |
| Kuhnz, W | 1 |
| Flor, S; Hahn, DW; Kafrissen, ME; McGuire, JL; Phillips, A; Tolman, EL | 1 |
| Alvarez, F; Brache, V; Diaz, J; el Mahgoub, S; Faundes, A; Jimenez, E; McCarthy, T; Mishell, DR; Shoupe, D; Sivin, I | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
| Broome, M; Fotherby, K | 1 |
| Andersch, B; Milsom, I; Sundell, G | 1 |
| Holck, S; Loke, DF; Ng, CS; Ratnam, SS; Samsioe, G | 1 |
| Back, DJ; Chadwick, DJ; Crawford, P; Martin, C; Orme, M; Tjia, J | 1 |
| Catz, P; Friend, DR | 1 |
| Pienaar, CA; Schall, R; Sohnius, U; van der Spuy, ZM | 1 |
| Burkman, RT | 1 |
| Hümpel, M; Li, QG | 1 |
| Borggaard, B; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Kloosterboer, HJ; Rekers, H | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Kamau, RK; Kigondu, C; Maina, FW; Mati, JK | 1 |
| Edén, S; Karlsson, R; von Schoultz, B | 1 |
| Burcher, E; Byrne, KB; Geraghty, DP; McPherson, GA | 1 |
| Juchem, M; Pollow, K | 1 |
| Kivinén, S; Palatsi, R; Reinilä, M | 1 |
| Baveja, R; Bichille, LK; Coyaji, KJ; Engineer, AD; Gogoi, MP; Hazra, MN; Kochhar, M; Lahiri, BC; Manuel, M; Nanda, UK | 1 |
| Holden, AE; Lähteenmäki, P; Luukkainen, T; Ratsula, K; Rosenthal, M; Shain, RN; Toivonen, J | 1 |
| Delbarge, W; Thiery, M; Van der Pas, H; Van Kets, H | 1 |
| Liew, D; Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 5 |
| Koh, S; Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 4 |
| Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
| Ratsula, K | 2 |
| Lähteenmäki, P; Luukkainen, T; Ratsula, K; Toivonen, J | 1 |
| Croft, P; Hannaford, P | 1 |
| Balogh, S; Fakeye, O | 1 |
| Aedo, AR; Johannisson, E; Kumar, A; Landgren, BM; Shi, YE | 1 |
| Goldzieher, JW | 2 |
| Mishell, DR; Shoupe, D | 1 |
| Alvarado, A; Darney, PD; Klaisle, CM; Monroe, SE | 1 |
| Chen, JK; Fotherby, K; He, ML; Song, S | 1 |
| Balogh, SA; Basnayake, S; Grubb, GS; Klavon, SL; Puertollano, N; Ramos, RM | 1 |
| Franke, H; Giese, R; Klinger, W; Kretzschmar, M; Machnik, G | 1 |
| Catz, P; Friend, DR; Heller, J; Okagaki, M | 2 |
| Akerlund, M; Ekström, P; Juchnicka, E; Laudanski, T | 1 |
| Catz, P; Friend, DR; Phillips, S | 1 |
| Taves, EH; Wolfe, BM | 1 |
| Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 2 |
| Maltau, JM; Oian, P; Omsjø, IH; Osterud, B | 1 |
| Li, QG; Nieuweboer, B | 1 |
| Plotka, ED; Seal, US | 1 |
| Garcia-Bragado, F; Grilo, A; Iriarte, LM; Lozano, F; Rivera, JM; Salgado, V | 1 |
| Chen, JH; Cheng, J; Luo, HZ; Wang, XP; Wu, MZ; Wu, SC; Xu, RH; Zhu, PD | 1 |
| Brandeis, A; Cárdenas, H; Croxatto, HB; Díaz, S; Pavez, M | 1 |
| Almer, S; Bodemar, G; Elfström, J; Franzén, L; Ihse, I; Resjö, M; Rydén, BO | 1 |
| Chen, JH; Cheng, J; Liu, YF; Luo, HZ; Song, GY; Wu, YM; Xu, RH; Zheng, WM; Zhou, ZH; Zhu, PD | 1 |
| Fitz, R; Grünberger, W; Vytiska-Binstorfer, E | 1 |
| Karunanithy, R; Leung, SL; Yeo, SH | 1 |
| Becker, C; Higgins, JE; McCann, MF; Moggia, AV; Potts, M | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Pedersen, LR; Refn, H; Schierup, L | 1 |
| Gu, SJ | 1 |
| Bagdon, RE; Bierman, RH; Chien, TY; Chien, YW; Huang, YC | 1 |
| Beastall, G; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Lindsay, R | 1 |
| de Silva, V; Farr, MG; Thapa, S | 1 |
| Croxatto, HB; Díaz, S; Miranda, P; Pavez, M; Quinteros, E | 1 |
| Beck, WW | 1 |
| Laird, M; Monier, M | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Le Donne, M | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Sundén, M | 1 |
| Bardin, CW | 1 |
| Nosher, J; Pasquale, S; Thomsen, RJ | 1 |
| Alvarez, F; Brache, V; Faundes, A; Tejada, AS | 3 |
| Gaspard, UJ; Lepot, MR | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Harenberg, J; Kohlmeier, M; Rabe, T; Runnebaum, B; Weicker, H | 1 |
| Skouby, SO | 1 |
| Burcher, E; Byrne, KB; Coupar, IM; Stanton, BJ | 1 |
| Gahn, G; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Gahn, G; Gross, W; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Aleksandrovskaia, TN; Dubnitskaia, LV; Manuilova, IA; Shallaeva, VV | 1 |
| Ide, P; Wynants, P | 1 |
| Ayeni, O; Chalapati, S; Crawford, MA; Drury, PJ; Dusitsin, N; Gellen, JJ; Lenihan, T; Pinol, A; Sas, M; Tunkeyoon, M | 1 |
| Mall-Haefeli, M | 1 |
| Keller, PJ | 1 |
| Kloosterboer, HJ; van den Ende, A; van Wayjen, RG | 1 |
| Odlind, V | 1 |
| Fraser, IS | 1 |
| Huber, J; Spona, J | 1 |
| Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
| Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
| Hoppe, G | 1 |
| Bonnar, J | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Kuusi, T; Tikkanen, MJ; Viinikka, L; Ylikorkala, O | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Winzer, M; Wolff, HH | 1 |
| Erkkola, R; Grönroos, M; Järnström, S; Liukko, P; Näntö, V; Pakarinen, P | 1 |
| Bergink, EW; Erkkola, R; Liukko, P | 1 |
| Desager, JP; Gaspard, U; Harvengt, C; Lepot, M | 1 |
| Belsey, EM | 2 |
| Belsey, EM; Peregoudov, S | 1 |
| Belsey, EM; Carlson, N; d'Arcangues, C | 1 |
| Chailurkit, L; Phiromsawat, S; Rojanasakul, A; Sirimongkolkasem, R | 1 |
| Benraad, TJ; Meulenberg, PM; Ross, HA; Swinkels, LM | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
| Varma, TR | 2 |
| Chalmers, JS; Cowen, PJ; Fulli-Lemaire, I | 1 |
| Stenman, UH; Vartiainen, E; Widholm, O; Ylöstalo, P | 1 |
| Burcher, E; Geraghty, DP | 1 |
| Balslev, I; Christensen, M; Støckel, M | 1 |
| Hertz, R; Spiro, I; Zook, BC | 1 |
| Rådberg, G; Svanvik, J | 1 |
| Back, DJ; Chadwick, D; Cleland, P; Cowie, A; Crawford, P; Orme, ML; Tjia, J | 1 |
| Back, DJ; Cowie, A; Gilmore, I; Grimmer, SF; Orme, ML; Tjia, J | 1 |
| Annus, J; Apró, G; Bartfai, G; Belsey, E; Bulpitt, C; Kovacs, L; Pinol, A | 1 |
| Allonen, H; Haukkamaa, M; Lähteenmäki, P; Luukkainen, T; Nilsson, CG; Toivonen, J | 1 |
| Lahteenmaki, PL; Luukkainen, T; Nilsson, CG; Robertson, DN | 1 |
| Joshi, JV; Joshi, UM; Sankolli, GM; Shah, RS | 1 |
| Bardin, CW; Basdevant, A; Conard, J; Corvol, P; Elkik, F; Guy-Grand, B; Jackanicz, TM; Mercier-Bodard, C | 1 |
| Liew, DF; Ng, CS; Ratnam, SS; Yong, YM | 1 |
| Datey, S; Hingorani, V; Jalnawala, SF; Kochhar, M; Mehta, S; Rai Chaudhury, G; Roy, M; Saxena, BN; Saxena, NC; Sengupta, PC | 1 |
| Odlind, V; Olsson, SE | 2 |
| Madhavan Nair, K; Narasinga Rao, BS; Prema, K; Sivakumar, B | 2 |
| Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP | 1 |
| Hale, R | 1 |
| Croxatto, HB; Díaz, S; Herreros, C; Johansson, ED; Pavez, M | 1 |
| Abdullah, KA; Gomaa, AA; Odlind, V; Salem, HT; Shaaban, MM | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Orme, ML; Osman, F | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Makeram, M; Orme, ML; Osman, F; Salem, H | 1 |
| Lopez, G; Rengifo, J; Rodriguez, A; Sivin, I | 1 |
| Aedo, AR; Cekan, SZ; Diczfalusy, E; Landgren, BM | 1 |
| Gao, J; Ma, LY; Song, GY; Sun, HZ | 1 |
| Arko, H; Haukkamaa, M; Luukkainen, T; Nilsson, CG; Silverberg, SG | 1 |
| Haukkamaa, M | 1 |
| Godsland, I; Wynn, V | 1 |
| Amer, S; el-Ghazzawi, E; Toppozada, M | 1 |
| Chiang, S; Goebelsmann, U; Hoffman, D; Woutersz, T | 1 |
| Betrabet, SS; Datey, S; Patel, DM; Saxena, BN; Shikary, ZK; Toddywala, WS | 1 |
| Collins, DC; Gould, KG; Kessler, MJ; Mann, DR; Smith, MM | 1 |
| Alvarez, F; Belhadj, H; Brache, V; Breaux, H; Diaz, S; Mishell, DR; Pavez, M; Shoupe, D; Sivin, I; Tejada, AS | 1 |
| Fredricsson, B; Hirt, M; Lagrelius, A; Weintraub, L | 1 |
| Bayard, F; Dupont, MA; Gas, N; Jozan, S; Roubinet, F; Valette, A | 1 |
| Anderson, AE; Ayerst, RI; Curtis, MK; Ellsworth, HS; Harris, JW; Jones, TL; Stone, RA | 1 |
| Dhaliwal, LK; Gulati, K; Gupta, AN | 1 |
| Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO | 1 |
| Khokha, R; Possmayer, F; Walton, PA; Wolfe, B | 1 |
| Odlind, V; Olsson, SE; Wide, L | 1 |
| Bonnar, J; Hourihan, HM; Sheppard, BL | 1 |
| Ehnholm, C; Heikkinen, JE; Luoma, PV; Ylöstalo, PR | 1 |
| Siemens, AJ | 1 |
| Koritnik, DR; Marschke, KB | 1 |
| Affandi, B; Karmadibrata, S; Lubis, F; Prihartono, J; Samil, RS | 1 |
| Collins, DC; Gould, KG; Mann, DR; Schleicher, RL | 1 |
| Ambrosecchia, R; Bagni, B; Bassi, P; Bergamini, CM; Cavallini, AR; Meduri, P; Pansini, F | 1 |
| Bertina, RM; Gevers Leuven, JA; Hessel, LW; Kluft, C | 1 |
| Belopavlović, Z; Vukelić, J | 1 |
| Affandi, B; Boonkasemsanti, W; Cekan, SZ; Diczfalusy, E; Samil, RS | 1 |
| Adams, MR; Clarkson, TB; Koritnik, DR; Nash, HA | 1 |
| Cajander, S; Holst, J; von Schoultz, B | 1 |
| Sandvei, R; Steier, AJ; Ulstein, M | 1 |
| Dreisler, A; Kühl, C; Petersen, KR; Skouby, SO | 1 |
| Albus, C; Männchen, E | 1 |
| Back, DJ; Grimmer, SF; Orme, ML; Rogers, SM; Stevenson, PJ | 1 |
| Anwar, MY; Ismail, AA; Toppozada, M; Youssef, SM | 1 |
| Johansson, ED; Nordström, ML; Odlind, V; Olsson, SE | 1 |
| Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Mattos, CE; Pavez, M; Sivin, I; Stern, J | 1 |
| Kung, AW; Lam, KS; Li, DF; Ma, HK; Ma, JT; Ng, MM; Wang, CC; Wong, VC; Young, RT | 1 |
| Back, DJ; Batten, JC; Grimmer, SF; Hodson, ME; Orme, ML; Rogers, SM; Stead, RJ | 1 |
| Hammond, GL; Odlind, V; Olsson, SE | 1 |
| Betrabet, SS; Jhaveri, K; Joshi, JV; Patel, DM; Patel, S; Patel, ZM; Saxena, BN; Shikary, ZK; Toddywala, SP; Toddywala, VS | 1 |
| Gu, SJ; Weng, LJ | 1 |
| Olsson, SE | 1 |
| Betrabet, SS; Patel, D; Saxena, BN; Shikary, ZK; Toddywalla, SP; Toddywalla, VS | 1 |
| Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM | 1 |
| Croxatto, HB; Díaz, S; Johansson, ED; Miranda, P; Pavez, M | 1 |
| Cárdenas, H; Croxatto, HB; Díaz, S; Pavez, M | 1 |
| Sheppard, BL | 1 |
| Friman, S; Rådberg, G; Samsioe, G; Svanvik, J | 1 |
| Badrawi, HH; Edelman, DA; Van Os, WA | 1 |
| Gillmer, MD | 1 |
| Hale, RW | 1 |
| Segal, S | 1 |
| Bártfai, G; Bhattacharjee, SK; Boukhris, R; Kononova, ES; Prasad, RN; Pretnar-Darovec, A; Romeo, J; Saraya, L; Shi, YE; Van Look, PF | 1 |
| Brandeis, V; Cruz, RI; Kelly, S; Pasquale, SA; Sweeney, M | 1 |
| Back, DJ; Cohen, M; Elstein, M; Killick, SR; Shenoy, N; Stevenson, PJ | 1 |
| D'Ambrosio, R; Gardner, MJ; Jusko, WJ; Kanarkowski, R; Tornatore, KM | 1 |
| Tydén, T | 1 |
| Digranes, A; Hofstad, T; Sandvei, R; Steier, AJ; Ulstein, M | 1 |
| Allonen, H; Andersson, K; Batar, I; Haukkamaa, M; Holma, P; Lampe, L; Luukkainen, T; Pyörälä, T; Terho, J; Toivonen, J | 1 |
| Brandeis, A; Croxatto, HB; Díaz, S; Ebensperger, C; Morales, P; Salvatierra, AM | 1 |
| Affandi, B; Hadisaputra, W; Lubis, F; Moeloek, FA; Prihartono, J; Samil, RS; Santoso, SS | 2 |
| Etchepareborda, JJ; Kesseru, E; Videla-Rivero, L | 1 |
| Destée, A; Leys, D; Petit, H; Warot, P | 1 |
| Kirk, ME; Nisker, JA; Nunez-Troconis, JT | 1 |
| Akerlund, M; Forsling, ML; Hauksson, A; Kindahl, H | 1 |
| Eenink, MJ; Feijen, J; Molenaar, I; Nieuwenhuis, P; Olijslager, J; Oosterbaan, JA; Potman, W; Schakenraad, JM | 1 |
| Affandi, B; Lubis, F; Prihartono, DJ; Samil, RS; Suherman, SK | 1 |
| Back, DJ; Grimmer, SF; Orme, ML; Rogers, S; Stevenson, PJ | 1 |
| Dallenbach-Hellweg, G | 1 |
| Almkvist, O; Larsson, B; Silber, M; Stock, S; Uvnäs-Moberg, K | 1 |
| Nattrass, M; Nutter, SA; Singh, BM | 1 |
| Ahlesteen, I; Astedt, B; Kjaeldgaard, A; Larsson, B | 1 |
| Grond, AJ; Janssens, AR; Kreuning, J; Kroon, HM; Ruiter, DJ; van Erpecum, KJ | 1 |
| Johansson, ED; Odlind, V; Olsson, SE; Sivin, I | 1 |
| Agarwal, K; Bajpai, VK; Sethi, N; Singh, RK | 1 |
| Christaens, GC; Haspels, AA; Scholten, PC | 1 |
| Fotherby, K; He, CH; Shi, YE; Yu, PP; Zheng, SH; Zhu, YH | 1 |
| Das, S; Dash, DS; Nanda, U; Samal, KC; Tripathy, BB | 1 |
| de Castro, AM; de Castro, ML; Giovanini, ME; Gomes, FM; Koifman, S; Mota, LG; Oliveira, DP; Paes, SJ; Poyares, JA; Vianna, NF | 1 |
| Haspels, AA | 2 |
| Dooley, M; Fogelman, I; Montgomery, J; Murby, B; Savvas, M; Studd, JW | 1 |
| Husain, FA; Khan, T | 1 |
| Ellingson, AB; Kotlik, A; Spellacy, WN; Tsibris, JC | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Allonen, H; Ratsula, K; Toivonen, J | 1 |
| Nair, KM; Prasad, KV; Rao, BS; Sivakumar, B | 2 |
| Dai, MZ; Li, LZ; Liu, CQ; Liu, GM; Shen, SR; Zhu, JY | 1 |
| Hsieh, CM; Lu, WY; Nan, ZY; Xu, MH | 1 |
| Cárdenas, H; Croxatto, HB; Díaz, S; Johansson, ED; Larsson, M; Pavez, M | 1 |
| Brandeis, A; Croxatto, HB; Díaz, S; Pavez, M | 1 |
| Abdelhamid, AM; Tag-el-Den, TH | 1 |
| Du, MG; Gao, YL; Gu, SJ; Liu, YL; Wang, PZ; Wang, SH; Wu, SL; Xu, MF; Yuan, DY; Zhang, LD | 1 |
| Chaudhury, N; Gupta, AN; Hazra, MN; Hingorani, V; Kochhar, M; Kodkany, BS; Logambal, A; Nanda, UK; Rai Choudhary, G; Raja Ram, P | 1 |
| DeAngelis, NJ; Eickhoff, WM; Jackman, JK; Reif, VD | 1 |
| Cekan, SZ | 1 |
| Arriaza, A; Campodónico, I; Franck, C; Lavín, P; Martínez, M; Pizarro, S; Robinovich, J; Urzúa, E | 1 |
| Demeter, J; Gáti, I; Gerö, G; Rákóczi, I | 1 |
| Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 4 |
| Buret, J; Gaspard, UJ; Gillain, D; Lambotte, R; Romus, MA | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 3 |
| von Schoultz, B | 1 |
| Käär, K; Ruokonen, A | 1 |
| Donde, UM; Joshi, JV; Joshi, UM; Sankoli, GM; Saxena, BN; Virkar, KD | 1 |
| Johansson, ED; Kock, NG; Kral, JG; Nilsson, LO; Victor, A | 1 |
| Jemilev, ZA; Komor, A; Schubert, K; Strecke, J | 1 |
| Holma, P | 1 |
| Alvarez, F; Brache, V; Faúndes, A; Johansson, E | 1 |
| Niddam, R; Perrot-Marsault, M | 1 |
| Croxatto, HB; Díaz, S; Pavez, M | 1 |
| Alvarez-Sanchez, F; Brache, V; Coutinho, E; Croxatto, HB; Diaz, S; Faundes, A; Holma, P; Lacarra, M; Mishell, DR; Robertson, DN | 1 |
| Cekan, SZ; Diczfalusy, E; Jia, M; Landgren, BM | 1 |
| Heller, J | 1 |
| Koch, M; Peschke, T; Stracke, R | 1 |
| Maity, CR; Mandal, B | 2 |
| Tiltman, AJ | 1 |
| Garrett, D; Wren, B | 1 |
| Brandeis, A; Croxatto, HB; Díaz, S; Johansson, ED; Pavez, M | 1 |
| Heller, J; Himmelstein, KJ | 1 |
| Bierschwale, M; Castiglione, A; Novoa, O | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 1 |
| Christensen, MS; Kühl, C; Mølsted-Pedersen, L; Petersen, K; Skouby, SO | 1 |
| Bayard, F; David, JF; Faye, JC; Jozan, S; Tauber, JP; Tournier, JF | 1 |
| Holma, P; Robertson, DN | 1 |
| Abdulla, KA; Elwan, SI; Salem, HS; Shaaban, MM | 1 |
| Hahn, DW; Hetyei, NS; Killinger, J; McGuire, JL; Phillips, A | 1 |
| Feng, DD; Xiao, BL; Zhang, XL | 1 |
| Iohan, F; Jackanicz, T; Monder, C | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM; Xing, S | 1 |
| Abdullah, KA; Salem, HT; Shaaban, MM | 1 |
| Becket, G; Karunanithy, R; Leung, SL; Yeo, SH | 1 |
| Farkas, E; Farkas, M; Sas, M | 1 |
| Csermely, T; Székely, J; Vértes, M | 1 |
| Beck, LR; Gilley, RM; Pope, VZ; Tice, TR | 1 |
| Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Peralta, O | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Hirvensalo, E; Liukko, P; Malmiharju, T; Mattila, L; Palatsi, R; Riihiluoma, P; Ylöstalo, P | 1 |
| Esber, HJ; Gregory, JB; Rosenkrantz, H; Wise, DL | 1 |
| Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG | 3 |
| Ehnholm, C; Kostiainen, E; Nilsson, CG | 1 |
| Back, DJ; Breckenridge, A; Orme, M; Shaw, MA | 1 |
| Freund, H; Freund, R; Kurischko, A; Meyer, M; Oettel, M; Stölzner, W | 1 |
| Bergink, EW; Borglin, NE; Klottrup, P; Liukko, P | 1 |
| Samsioe, G | 1 |
| Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
| Alapiessa, U; Lund, L; Nummi, S; Ruokonen, A; Viinikka, L | 1 |
| Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
| de Visser, J; van der Vies, J | 1 |
| Cersosimo, L; Consalvo, F; Iannucci, D; Orgiu, G | 1 |
| Demey-Ponsart, E; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D; Romus, MA | 1 |
| Abrahamsson, L; Hackl, H; Orstam, S | 1 |
| Hammond, GL; Langley, MS; Lund, L; Nummi, S; Robinson, PA | 1 |
| Klove, KL; Lobo, RA; Roy, S | 1 |
| Bergink, EW; Kloosterboer, HJ; Lund, L; Nummi, S | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
| Düsterberg, B | 1 |
| Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
| Tatum, HJ | 1 |
| Casagrande, J; Krauss, RM; Mishell, DR; Pike, MC; Roy, S | 2 |
| Adashi, EY | 1 |
| Acorn, T; Ling, WY; Popat, R; Wilson, E; Wrixon, W; Zayid, I | 1 |
| Hammond, CB; Hendren, RW; Ory, SJ; Pitt, CG; Yancy, SG | 1 |
| Roy, SK; Srivastava, AK | 1 |
| Christie, T | 1 |
| Guillebaud, J | 1 |
| Moggia, AV | 1 |
| Woutersz, TB | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Durán, E; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 3 |
| Alvarez, F; Brache, V; Faundes, A; Johansson, ED; Nash, H; Odlind, V | 1 |
| Croxatto, HB; Diaz, S; Pavez, M; Robertson, DN | 1 |
| Deville, JL; Dubois, M; Gaspard, UJ | 1 |
| Chemnitius, KH; Dietz, K; Freund, H; Hesse, G; Oettel, M; Raj, MH; Stölzner, W | 1 |
| Härtl, A; Hillesheim, HG; Hoffmann, H; Kirchner, E; Knappe, H; Tkocz, R | 1 |
| Hillesheim, HG; Hoffmann, H | 1 |
| Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U | 1 |
| Goncharov, NP; Komor, A; Oettel, M; Schubert, K | 1 |
| Coutinho, E; Diaz, S; Holma, P; McDonald, O; Robertson, DN; Sanchez, FA; Sivin, I; Stern, J | 1 |
| Briggs, M | 2 |
| Alvarez, F; Coutinho, E; Faundes, A; Johansson, E | 1 |
| Kurunmäki, H | 1 |
| Braun, J; Dinh, J; Nash, HA; Robertson, DN; Sivin, I | 1 |
| Bergqvist, A; Bergqvist, D; Tangen, O | 1 |
| Cekan, SZ; Diczfalusy, E; Johannisson, E; Landgren, BM; Toddyvalla, V | 1 |
| Allen, WL; Back, DJ; Breckenridge, AM; Grimmer, SF; Orme, M; Tjia, J | 1 |
| Foegh, M | 1 |
| Guillebaud, J; Kubba, AA | 1 |
| Gommaa, AA; Osman, FH | 1 |
| Adams, MR; Clarkson, TB; Moo-Young, AJ; Nelson, CA; Rudel, LL; Thau, RB | 1 |
| Fåhraeus, L; Larsson-Cohn, U; Wallentin, L | 1 |
| Faúndes, A; Gomez, F; Hardy, EE; Portes-Carrasco, R; Reyes, Q | 1 |
| Johansson, ED; Lithell, H; Vessby, B; Weiner, E | 1 |
| Colau, JC; de Gennes, JL; Gheron, G; Taurelle, R | 1 |
| Francisco, CG; Freire, R; García, GA; Go, ML; Hernandez, R; Leung, SL; Ngiam, TL; Salazar, JA; Suarez, E; Wan, AS | 1 |
| Ponsold, K; Savabi, F; Schubert, K; Shafiee, A; Tarpanov, V; Vlahov, R; Vossoghi, M; Wagner, H; Watson, TG; Werner, W | 1 |
| Chan, L; Hadjigeogiou, P; Matlin, SA; Mehani, S; Prazeres, MA; Roshdi, S | 1 |
| Fotherby, K; Naderi, S | 1 |
| Bialy, G; Blye, RP; Enever, RP; Lindberg, MC; Naqvi, RH | 1 |
| Agnihotri, A; Kamboj, VP; Srivastava, AK; Tandon, P | 1 |
| Lähteenmäki, PL; Luukkainen, T; Nilsson, CG | 1 |
| Dechavanne, M; Guichardant, M; Lagarde, M; Quincy, C; Sassolas, A | 1 |
| Farish, E; Fletcher, CD; Hart, DM; Lindsay, R; Sharpe, GL | 1 |
| Dessole, S; Firinu, C; Milia, S; Piras, G | 1 |
| Duda, MJ; Krauss, RM; Lacarra, M; Mishell, DR; Robertson, DN; Roy, S | 1 |
| Andersen, O; Skouby, SO; Wagner, HH | 1 |
| Puolakka, J; Viinikka, L; Ylikorkala, O | 1 |
| Cerskus, I; Hedlin, AM; Kakis, G; Powell, MG; Prudham, D; Rosenrot, P | 1 |
| Jones, RC | 1 |
| Aaserud, J; Bratt, H; Fylling, P; Lie, S; Schiefloe, A; Steier, A; Svendsen, E; Ulstein, M | 1 |
| Kurunmäki, H; Lähteenmäki, PL; Luukkainen, T; Toivonen, J | 2 |
| Gil, J; Jiménez, JL; Otero González, A; Sánchez-Guisande, D; Santos, C; Temes Montes, XL | 1 |
| Dubois, M; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D | 1 |
| Salah, M; Shaaban, MM | 1 |
| Beier, S; Düsterberg, B | 1 |
| Diczfalusy, E; Landgren, BM | 1 |
| Abdel Wareth, AA; Gomaa, AA; Osman, FH; Salem, HT | 1 |
| Koch, M | 1 |
| Delezé, M; Gutiérrez, G; Mintz, G; Rodríguez, E | 1 |
| Elder, MG; Fotherby, K; Hamawi, A; Lawson, JP; Lucas, S; Trayner, I | 1 |
| Lindberg, MC; Mitra, SB; Naqvi, RH; Saksena, IF | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Ahrendt, HJ; Ahrendt, S; Canzler, E | 1 |
| Khokha, R; Wolfe, BM | 1 |
| Amatayakul, K; Ruckphaopunt, S; Singkamani, R; Uttaravichai, C | 1 |
| Dagan, I; Gross, V; Landau, H; Palti, Z; Rachmilewitz, EA; Spitz, IM | 1 |
| Back, DJ; Breckenridge, AM; Grimmer, SF; Orme, ML; Purba, HS | 1 |
| Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
| Abdel-Aleem, AM; el-Nashar, IM; Ghaneimah, SA; Gomaa, AA; Salah, M; Shaaban, MM | 1 |
| el-Sharkawy, MM; Elwan, SI; Farghaly, AS; Shaaban, MM | 1 |
| Abdalla, SA; Darwish, HA; Elwan, SI; Shaaban, MM | 1 |
| el-Kabsh, MY; Elwan, SI; Farghaly, SA; Shaaban, MM; Thabet, N | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Pavez, M; Sivin, I | 1 |
| Chandra, G; Roy, SK; Srivastava, AK | 1 |
| Lindberg, MC; Mitra, SB; Naqvi, RH | 1 |
| Briggs, MH; Thomson, SB; Tucker, DJ | 1 |
| Spasojević, M | 1 |
| Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 3 |
| Düsterberg, B; Hümpel, M; Speck, U | 1 |
| Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 2 |
| Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST | 1 |
| Lähteenmäki, P; Luukkainen, T; Nilsson, CG | 2 |
| Fotherby, K; Jenkins, N | 2 |
| Englund, D; Nilsson, O; Victor, A; Weiner, E | 1 |
| Gentzschein, E; Lumkin, M; Mishell, DR; Roy, S; Stanczyk, F | 1 |
| Corker, CS; Føgh, M; Hunter, WM; McLean, H; Petersen, IB; Philip, J; Schou, G; Skakkebaek, NE | 1 |
| Hesse, G; Kurischko, A; Löw, O; Oettel, M; Tkocz, H | 1 |
| Heywood, R; Lewis, DJ; Wadsworth, PF | 1 |
| Mishell, DR; Nakamura, RM; Stumpf, PG | 1 |
| Elstein, M; Nuttal, ID | 1 |
| Holma, P; Nilsson, CG | 1 |
| Back, DJ; Bates, M; Breckenridge, AM; Ellis, A; Hall, JM; Maciver, M; Orme, ML; Rowe, PH | 1 |
| Lehtovirta, P; Ranta, T; Seppälä, M | 1 |
| Croxatto, HB; Díaz, S; Elamsson, K; Johansson, ED; Miranda, P | 1 |
| Back, DJ; Bates, M; Breckenridge, AM; Hall, JM; MacIver, M; Orme, ML; Park, BK; Rowe, PH | 1 |
| Love, AH; Vir, SC | 1 |
| Alvarado Durán, A; Aznar, R; Gallegos, A; González Diddí, M; Pedrón, N | 1 |
| Bayard, F; Jozan, S; Kreitmann, B | 1 |
| Kurunmäki, H; Lähteenmäki, P; Luukkainen, T; Toivonen, J | 1 |
| Nair, KM; Rao, BS; Sivakumar, B | 1 |
| Boccardo, E; Larosa, E; Ragni, N; Viglino, S | 1 |
| Capel, ID; Donaldson, D; Jenner, M; Nath, A; Williams, DC | 1 |
| Obel, EB | 1 |
| Jackanicz, TM | 1 |
| Ahrén, T; Johansson, ED; Lithell, H; Victor, A | 1 |
| Ahrén, T; Johansson, ED; Lithell, H; Vessby, B; Victor, A | 2 |
| Alvarez, F; Brache, V; Faundes, A; Leon, P; Robertson, DN; Sivin, I; Stern, J | 1 |
| Mishell, DR; Roy, S; Wilkins, J | 1 |
| Jemilev, ZA; Komor, A; Oettel, M; Schubert, K; Strecke, J | 1 |
| Haukkamaa, M; Heikkilä, M; Luukkainen, T | 1 |
| Heikkinen, J; Jänne, O; Mäentausta, O; Ylöstalo, P | 1 |
| Osborn, RA; Wren, BG | 1 |
| Wynn, V | 2 |
| Kay, CR | 1 |
| Niththyananthan, R; Wynn, V | 1 |
| Meade, TW | 1 |
| Adatia, A; Andolsek, L; Ayeni, S; Belsey, MA; Hall, PE; Jain, U; Li Hoi Foo, C; Parker, RA; Patankar, S; Pinol, A; Pretnar-Darovec, A; Sharma, S; Sheth, A | 1 |
| Nilsson, CG | 1 |
| Heikkilä, M; Luukkainen, T | 1 |
| Kühl, C; Mølsted-Pedersen, L; Skouby, SO | 1 |
| Briggs, M; Briggs, MH | 1 |
| Wingrave, SJ | 1 |
| Fåhraeus, L; Larsson-Cohn, U; Wallentin, L; Zador, G | 1 |
| Myklebust, RU; Ulstein, M | 1 |
| Güttner, J; Hillesheim, HG; Hoffmann, H; Oettel, M | 1 |
| Back, DJ; Breckenridge, AM; MacIver, M; Orme, M; Rowe, PH; Staiger, C; Thomas, E; Tjia, J | 1 |
| El Mahgoub, S | 1 |
| Croxatto, HB; Diaz, S; Miranda, P; Pavez, M; Robertson, DN; Sivin, I | 1 |
| Hodsman, GP; Mackay, A; Robertson, JI; Semple, PF | 1 |
| Weir, RJ | 1 |
| Heikkilä, M | 1 |
| Alvarez-Sánchez, F; Brache, V; Faundes, A; León, P; Schmidt, F | 1 |
| Barbosa, IC; Coutinho, EJ; Coutinho, EM; Gonçalves, MT | 1 |
| Elamsson, K; Elmestedt, U; Johansson, ED | 1 |
| Goncharov, NP; Komor, A; Oettel, M | 1 |
| Hillesheim, HG; Hoffmann, H; Oettel, M; Strecke, J | 1 |
| Elamsson, K; Englund, DE; Johansson, ED; Odlind, V; Victor, A | 1 |
| Brandeis, A; Croxatto, HB; Diaz, S; Miranda, P; Pavez, M | 1 |
| Burrows, GD; Dennerstein, L | 1 |
| Cameron, ED; Elstein, M; McCafferty, E; Nuttall, ID; Seth, J | 1 |
| Bolis, PF; Franchi, M; Marino, L; Paganelli, AM; Sampaolo, P | 1 |
| Heikkilä, M; Lähteenmäki, P; Luukkainen, T | 1 |
| Boccardo, E; De Cecco, L; Ragni, N; Viglino, S | 1 |
| Bouffioux, R; Gaspard, U; Werbrouck-Navette, J | 1 |
| Jespersen, J; Kluft, C | 1 |
| Heikkilä, M; Luukkainen, T; Nylander, P | 1 |
| Doyen, J; Gaspard, U | 1 |
| Colin, C | 1 |
| Haukkamaa, M; Luukkainen, T; Nilsson, CG; Vierola, H | 1 |
| Cekan, SZ; Diczfalusy, E; Landgren, BM; Shi, S; Wang, E | 1 |
| Diczfalusy, E; Johannisson, E; Landgren, BM; Masironi, B | 1 |
| Croxatto, HB; Díaz, S; Miranda, P; Pavez, M; Sivin, I | 1 |
| Bolt, HM; Jung, R; Oesch, F; Peter, H | 1 |
| Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
| Butnev, VU; Goncharov, NP; Katzia, GV; Matikainen, T; Richkor, EG; Waites, GM | 1 |
| Berenson, AB; Wiemann, CM | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Blode, H; Kuhnz, W; Mahler, M | 1 |
| Beier, S; Kuhnz, W | 1 |
| Aguayo, EL; Calventi, V; de Silva, P; Dunson, TR; Gerais, AS; McLaurin, VL; Serani, RG | 1 |
| Chien, YW; Nair, M | 1 |
| Ho, PC; Kwan, MS | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Balasch, J; Sánchez-Borrego, R | 1 |
| Lidegaard, O | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| von Hertzen, H | 1 |
| Duda, M; Edom, RW; Huang, M; Juzwin, S; Tegegne, G; Tischio, JP; Wong, FA | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Creasy, GW; Fisher, AC; Lenihan, JP; Meador, ML; Shangold, GA; Smallwood, GH | 1 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Hoffmann, KO | 1 |
| Serfaty, D | 1 |
| Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W | 1 |
| Furlong, LA | 1 |
| Taneepanichskul, S; Tantbirojn, P | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| Bieniec, M; Bijak, A; Kochańska-Dziurowicz, AA; Stanjek, A; Szostek-Gaweł, V; Widala, E; Wróblewska-Adamek, I | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Levine, JP | 1 |
| Abramowitz, W; Jakate, AS; Kapil, R; Patel, A; Persiani, S; Roy, P; Wangsa, J | 1 |
| Chompootaweep, S; Leepipatpibul, S | 1 |
| Birtch, RL; Olatunbosun, OA; Pierson, RA | 1 |
| Szarewski, A | 1 |
| Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
| Jick, H; Jick, SS | 1 |
| Gupta, N | 1 |
| Burrows, M; Peters, C | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Tan, JK | 1 |
| Ensom, MH; Fielding, DW; Levine, M; Marciante, KD; Meckley, LM; Soon, JA | 1 |
| Buono, MJ; Martin, JG | 1 |
| Amaliev, G | 1 |
| Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA | 1 |
| Freeman, S; Shulman, LP | 1 |
| Weisberg, E | 1 |
| Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
| Chintedze, J; Cohen, MS; Corbett, A; Hosseinipour, M; Kashuba, AD; Kumwenda, W; Malunga, G; Mkandawire, N; Moses, A; Phiri, G; Stanczyk, FZ; Stuart, GS | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Lidegaard, O; Løkkegaard, E; Nielsen, LH; Skovlund, CW | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Nelson, AL | 1 |
| Archer, DF; Sriprasert, I; Stanczyk, FZ | 1 |
| Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Del Savio, MC; Facchinetti, F; Grandi, G | 1 |
| Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
| Bai, D; Bu, F; Fu, H; Gao, Y; Liu, M; Liu, Q; Liu, W; Ren, D; Shen, X; Si, X; Wan, X; Wang, Y; Wu, X; Yuan, S; Zhang, Z; Zhao, C; Zheng, A; Zheng, F | 1 |
28 review(s) available for norgestrel and levonorgestrel
| Article | Year |
|---|---|
Transdermal delivery of levonorgestrel.
Topics: Administration, Cutaneous; Animals; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Norgestrel; Skin Absorption | 1991 |
Levonorgestrel-releasing intrauterine device.
Topics: Contraceptive Agents, Female; Counseling; Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Norgestrel; Ovary | 1991 |
Subdermal progestin implant contraception.
Topics: Biodegradation, Environmental; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic | 1991 |
Levonorgestrel-releasing intrauterine device.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norgestrel | 1990 |
Pharmacokinetics of gestagens: some problems.
Topics: Biological Availability; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin | 1990 |
Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites.
Topics: Animals; Biotransformation; Contraceptives, Oral; Drug Combinations; Female; Humans; Levonorgestrel; Molecular Structure; Norgestrel; Oximes | 1990 |
Modern trends in contraception.
Topics: Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Intrauterine Devices; Levonorgestrel; Norgestrel | 1990 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Pharmacology of contraceptive steroids: a brief review.
Topics: Biological Availability; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; Norethindrone; Norgestrel | 1989 |
Norplant: subdermal implant system for long-term contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Contraception.
Topics: Age Factors; Contraception; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Postcoital; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Norgestrel | 1989 |
Long-acting steroidal contraception: an update.
Topics: Contraception; Contraceptives, Oral; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel | 1989 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Endometrial morphological changes in IUD users: a review.
Topics: Endometrium; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Progesterone | 1987 |
Intrauterine steroid contraceptives.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Prospective Studies | 1988 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
Ectopic pregnancy risk when contraception fails. A review.
Topics: Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Synthetic; Drug Approval; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Progesterone; Treatment Failure; United States; United States Food and Drug Administration | 2002 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Advances in hormonal contraception.
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraceptive Agents, Female; Contraceptives, Postcoital; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Female; Humans; Injections, Subcutaneous; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel | 2006 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
Transdermal contraception methods: today's patches and new options on the horizon.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 2015 |
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult | 2017 |
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism | 2021 |
172 trial(s) available for norgestrel and levonorgestrel
| Article | Year |
|---|---|
The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Time Factors; Triglycerides | 1979 |
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel | 1992 |
Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1992 |
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Corpus Luteum; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Time Factors | 1991 |
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Topics: Androgen Antagonists; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norgestrel; Severity of Illness Index | 1991 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Norgestrel; Pelvic Inflammatory Disease; Random Allocation | 1991 |
The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.
Topics: Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Drug; Female; Fertility; Humans; International Cooperation; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Norgestrel; United Kingdom; World Health Organization | 1991 |
Intrasubject variability in the pharmacokinetics of ethynyloestradiol.
Topics: Adult; Biological Availability; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1991 |
The lack of interaction between temafloxacin and combined oral contraceptive steroids.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Fluoroquinolones; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Progesterone; Quinolones; Radioimmunoassay | 1991 |
Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Cholesterol; Coronary Disease; Diet; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Rabbits | 1991 |
[Levonorgestrel releasing subcutaneous implants. 1st year's experience].
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pain; Patient Acceptance of Health Care | 1991 |
Serum lipids in Chinese patients using oral contraceptive pills.
Topics: Adult; China; Cholesterol; Congresses as Topic; Contraceptives, Oral; Desogestrel; Family Planning Services; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes | 1990 |
Study of Norplant implants in Shanghai: three-year experience.
Topics: Adult; China; Contraceptive Agents, Female; Drug Evaluation; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Thrombocytopenia; Time Factors | 1990 |
Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Tablets | 1990 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Contraception; Contraception Behavior; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pessaries; Pregnancy | 1990 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Contraception; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel | 1990 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Body Weight; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pregnancy | 1990 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Menstruation; Multicenter Studies as Topic; Norgestrel | 1990 |
Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China.
Topics: Administration, Intravaginal; Adult; alpha 1-Antitrypsin; Antithrombin III; China; Drug Implants; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Plasminogen | 1990 |
Comparative cross-over pharmacokinetic study on two types of postcoital contraceptive tablets containing levonorgestrel.
Topics: Absorption; Administration, Oral; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Norgestrel; Tablets | 1990 |
Pituitary, ovarian and endometrial effects of 300 micrograms norethisterone and 30 micrograms levonorgestrel administered on cycle days 7 to 10.
Topics: Adult; Contraceptives, Oral, Combined; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Ovary; Pituitary Gland; Progesterone | 1990 |
Metabolic changes during treatment with two different progestogens.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Fertilization; Hormones; Humans; Levonorgestrel; Lipid Mobilization; Lipids; Menstrual Cycle; Norgestrel; Norpregnenes; Random Allocation; Reference Values | 1990 |
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg.
Topics: Adult; Algestone; Algestone Acetophenide; Analysis of Variance; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Injections; Levonorgestrel; Multicenter Studies as Topic; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Triglycerides; White People | 1990 |
Clinical assessment of treatments for prolonged bleeding in users of Norplant implants.
Topics: Administration, Oral; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral; Drug Implants; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Ibuprofen; Levonorgestrel; Menstruation; Norgestrel | 1990 |
[Comparative study of norplant-2 and levonorgestrel-releasing intrauterine devices].
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel | 1990 |
Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive.
Topics: Adult; Analysis of Variance; Blood Glucose; Contraceptives, Oral, Combined; Female; Humans; Insulin; Levonorgestrel; Norethindrone; Norgestrel; Prospective Studies | 1990 |
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Topics: Adolescent; Adult; Amenorrhea; Copper; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Norgestrel; Patient Dropouts; Pelvic Inflammatory Disease | 1990 |
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Sex Hormone-Binding Globulin | 1990 |
A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Topics: Adolescent; Adult; Analysis of Variance; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Norgestrel; Triglycerides | 1990 |
Norplant contraceptive implants--a comparison of capsules versus rods in Singapore.
Topics: Adult; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel | 1990 |
Clinical and hormonal effects of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene.
Topics: Adult; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Radioimmunoassay; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Topics: Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Kenya; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel | 1990 |
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Norpregnenes; Pituitary Gland; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
Topics: Adolescent; Adult; Female; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Uterine Perforation | 1989 |
Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Topics: Adolescent; Adult; Clinical Trials as Topic; Consumer Behavior; Female; Finland; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Patient Acceptance of Health Care; Random Allocation | 1989 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
Topics: Adult; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Half-Life; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Ovary; Ovulation | 1989 |
Norplant: subdermal implant system for long-term contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Clinical evaluation of the Capronor contraceptive implant: preliminary report.
Topics: Administration, Cutaneous; Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Random Allocation | 1989 |
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 1. Comparisons with IUD. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Prospective Studies; Random Allocation; Time Factors; World Health Organization | 1989 |
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Time Factors; World Health Organization | 1989 |
Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
Topics: Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1989 |
The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 ca
Topics: Adult; Endometrium; Female; Foreign-Body Reaction; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Stainless Steel; Uterine Hemorrhage | 1989 |
The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Infant; Infant Nutritional Physiological Phenomena; Lactation; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene.
Topics: Adult; Antithrombin III; Apolipoproteins A; Blood Coagulation; Cholesterol, HDL; Contraceptives, Oral, Combined; Factor VII; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Prospective Studies | 1989 |
[Acceptability of norplant implantation in China].
Topics: Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Random Allocation | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Progesterone; Random Allocation | 1989 |
A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task force o
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation; Serum Albumin; Triglycerides | 1985 |
Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy, Ectopic; Random Allocation | 1987 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Clinical and metabolic effects of gestodene and levonorgestrel.
Topics: Adolescent; Adult; Blood Glucose; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Stereoisomerism | 1987 |
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Random Allocation; Testosterone | 1985 |
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phospholipids; Random Allocation; Triglycerides | 1985 |
An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on oral contraceptives.
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Double-Blind Method; Ethinyl Estradiol; Fatty Acids; Fatty Acids, Essential; Female; Humans; Hungary; Injections; Levonorgestrel; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Thailand | 1986 |
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1986 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies | 1988 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Menstruation Disturbances; Norgestrel; Patient Compliance; Patient Dropouts | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
Topics: Administration, Intravaginal; Africa; Asia; China; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Europe; Female; Humans; Latin America; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norgestrel; West Indies | 1988 |
The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Ileostomy; Kinetics; Levonorgestrel; Norgestrel; Time Factors | 1986 |
The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Structure-Activity Relationship; Time Factors | 1986 |
Five years' experience with levonorgestrel-releasing IUDs.
Topics: Adult; Amenorrhea; Female; Humans; Infections; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Random Allocation | 1986 |
Sustained intrauterine release of levonorgestrel over five years.
Topics: Clinical Trials as Topic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Time Factors | 1986 |
Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Topics: Adolescent; Adult; Amenorrhea; Clinical Trials as Topic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Oligomenorrhea; Random Allocation; Time Factors | 1986 |
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins | 1986 |
Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation | 1986 |
Two-year prospective study in Colombia of Norplant implants.
Topics: Adolescent; Adult; Clinical Trials as Topic; Colombia; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Pregnancy; Prospective Studies; Stereoisomerism | 1986 |
Clinical investigation of a low-dose levonorgestrel-releasing vaginal ring.
Topics: Adult; China; Clinical Trials as Topic; Contraception; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pessaries | 1986 |
The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel | 1986 |
Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device.
Topics: Adult; Clinical Trials as Topic; Female; Fertility; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Prospective Studies; Random Allocation | 1986 |
Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition.
Topics: Adult; Cholesterol; Cholesterol, HDL; Climacteric; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Triglycerides | 1986 |
Clinical performance with contraceptive vaginal rings containing levonorgestrel.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy | 1986 |
[Clinical experiences with a hormone-releasing intrauterine device].
Topics: Adult; Clinical Trials as Topic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel | 1987 |
[Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel | 1987 |
Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Estradiol; Female; Half-Life; Humans; Kinetics; Levonorgestrel; Norgestrel; Pregnancy; Sex Hormone-Binding Globulin | 1987 |
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Random Allocation | 1987 |
ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk.
Topics: Administration, Oral; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Infant, Newborn; Intrauterine Devices; Levonorgestrel; Milk, Human; Norgestrel | 1987 |
Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin; Thyroid Hormones; Thyroxine-Binding Proteins; Transcortin | 1987 |
ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Norgestrel; Pregnancy | 1987 |
Long-term follow-up of women treated with Norplant implants.
Topics: Adult; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Time Factors | 1987 |
A new delivery system for contraceptive steroids.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
Norplant contraceptive implants: rods versus capsules.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Random Allocation | 1987 |
The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
Topics: Adolescent; Adult; Biological Availability; Capsules; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Random Allocation; Tablets | 1987 |
Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
Topics: Adolescent; Adult; Cervix Uteri; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Prospective Studies; Random Allocation; Risk Factors; Vagina | 1987 |
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Random Allocation | 1987 |
Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Biological Availability; Ethinyl Estradiol; Female; Half-Life; Humans; Injections, Intravenous; Levonorgestrel; Norgestrel | 1987 |
Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Sweden | 1988 |
Clinical trial of a post-coital contraceptive pill.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Postcoital; Endometrium; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1988 |
[Multicenter clinical study of levonorgestrel contraceptive implants].
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Family Planning Services; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel | 1988 |
Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Time Factors; Triglycerides | 1985 |
Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
Topics: Androgens; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Endothelium; Esterification; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins; Lipoproteins, HDL; Liver; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1985 |
Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
Topics: Adolescent; Adult; Carrier Proteins; Ceruloplasmin; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Norpregnenes; Random Allocation; Sex Hormone-Binding Globulin | 1985 |
Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Time Factors | 1985 |
Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Silicone Elastomers; Skin; Time Factors | 1985 |
Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth.
Topics: Adolescent; Adult; Breast Feeding; Child Development; Clinical Trials as Topic; Drug Implants; Female; Humans; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Menstruation Disturbances; Milk, Human; Norgestrel; Pregnancy | 1985 |
Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
Topics: Adult; Capsules; Cholesterol; Cholesterol, HDL; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1985 |
Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel.
Topics: Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovulation; Progesterone; Vagina | 1985 |
A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Norgestrel; Pregnancy; Progesterone; Silicone Elastomers; Stereoisomerism; Vagina | 1985 |
Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Intrauterine Devices; Lactation; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1985 |
Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism; Testosterone | 1984 |
Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pain; Random Allocation | 1981 |
Progestagens and high-density lipoproteins.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1984 |
Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Random Allocation | 1984 |
Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glycoproteins; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism; Triglycerides | 1984 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Topics: Adolescent; Adult; Brazil; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Finland; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Outpatient Clinics, Hospital; Pain; Pregnancy; Random Allocation; Uterine Hemorrhage | 1983 |
Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Norethindrone; Norgestrel; Triglycerides | 1983 |
Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Endometrium; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Levonorgestrel; Norgestrel; Ovary; Progesterone | 1983 |
The 150/30 formulation. Experience in the United Kingdom.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Risk; Smoking; Stereoisomerism; United Kingdom | 1983 |
Clinical experience with a low-dose contraceptive agent. European studies.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Digestive System; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Latin America; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth.
Topics: Adult; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Three-year experience with NORPLANT subdermal contraception.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Implants; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Norgestrienone; Pain; Patient Dropouts; Pregnancy | 1983 |
Plasma lipids in women using progestogen-only oral contraceptives.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Female; Humans; Lactation; Levonorgestrel; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Norethindrone; Norgestrel; Pregnancy; Triglycerides | 1983 |
The influence of oral contraceptives on activated factor X inhibitor (XaI)-activity: a prospective study.
Topics: Adult; Antithrombin III; Contraceptives, Oral, Combined; Ethinyl Estradiol; Factor X; Factor Xa; Female; Humans; Levonorgestrel; Norgestrel; Prospective Studies | 1983 |
Evaluation of steroids as contraceptives in men.
Topics: Adult; Clinical Trials as Topic; Contraceptive Agents, Male; Contraceptives, Oral; Contraceptives, Oral, Combined; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Male; Middle Aged; Norgestrel; Sperm Count; Spermatozoa; Testosterone; Time Factors | 1983 |
L-norgestrel and progesterone have different influences on plasma lipoproteins.
Topics: Cholesterol; Contraceptives, Oral, Combined; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Phospholipids; Progesterone; Triglycerides | 1983 |
Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Topics: Adolescent; Adult; Capsules; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Silicone Elastomers; Uterine Hemorrhage | 1984 |
Effects of oral contraceptives on lipoprotein lipids: a prospective study.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Mestranol; Norgestrel; Triglycerides | 1984 |
Clinical experience with a triphasic oral contraceptive.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Uterine Hemorrhage | 1984 |
Contraception with progestagens in systemic lupus erythematosus.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lupus Erythematosus, Systemic; Norethindrone; Norgestrel; Stereoisomerism | 1984 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1984 |
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides | 1980 |
Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.
Topics: Adult; Clinical Trials as Topic; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Male; Middle Aged; Norgestrel; Placebos; Sperm Count; Spermatogenesis; Spermatozoa; Testosterone | 1980 |
Steroid releasing vaginal rings.
Topics: Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Medroxyprogesterone; Norethindrone; Norgestrel; Ovulation; Patient Acceptance of Health Care; Progesterone; Progestins | 1980 |
A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles.
Topics: Adult; Blood Proteins; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Norgestrel; Random Allocation; Stereoisomerism | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina | 1981 |
A randomized, double-blind study of six combined oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Random Allocation | 1982 |
A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norgestrel; Pregnancy; Random Allocation | 1982 |
Randomized prospective studies on metabolic effects of oral contraceptives.
Topics: Adult; Blood Coagulation Factors; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Levonorgestrel; Lipids; Norgestrel; Prospective Studies; Random Allocation; Renin-Angiotensin System | 1982 |
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations of the lipoprotein status.
Topics: Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Phospholipids; Random Allocation; Sex Hormone-Binding Globulin; Triglycerides | 1982 |
Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?
Topics: Adolescent; Adult; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lynestrenol; Norgestrel; Progestins; Triglycerides | 1982 |
Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Random Allocation | 1982 |
Long-term intracervical contraception with a levonorgestrel device.
Topics: Adult; Biopsy; Cervix Mucus; Cervix Uteri; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Pain; Pregnancy; Vaginal Smears | 1982 |
A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Topics: Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstruation; Norgestrel | 1982 |
Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adult; Breast Feeding; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Metrorrhagia; Middle Aged; Migraine Disorders; Norgestrel; Postpartum Period; Pregnancy | 1982 |
[Controlled studies on the oral administration of progestagens, an antiestrogen and vitamin B6 in the treatment of mastodynias].
Topics: Administration, Oral; Breast Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Pain; Pyridoxine | 1982 |
[Regulation of fertility by means of vaginal rings medicated with estradiol and levonorgestrel].
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Evaluation Studies as Topic; Female; Humans; Levonorgestrel; Norgestrel | 1982 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1994 |
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Chile; Contraceptives, Oral, Combined; Dominican Republic; Ecuador; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Sri Lanka; Sudan | 1993 |
A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Hong Kong; Humans; Levonorgestrel; Norgestrel; Pregnancy; Prospective Studies | 1993 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Efficacy and safety of a transdermal contraceptive system.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy | 2001 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
Topics: Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Pentanoic Acids; Receptors, Cholecystokinin | 2005 |
Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovarian Follicle; Time Factors; Ultrasonography | 2006 |
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports | 2006 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Feasibility Studies; Female; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Levonorgestrel; Malawi; Nevirapine; Norgestrel; Ovulation Inhibition; Progesterone; Stavudine; Young Adult | 2011 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
453 other study(ies) available for norgestrel and levonorgestrel
| Article | Year |
|---|---|
The effect of low-dose oral contraceptives and Norplant on blood pressure and body weight of Nigerian women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Implants; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Nigeria; Norgestrel; Prospective Studies | 1992 |
Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Protein Binding; Sex Hormone-Binding Globulin; Time Factors | 1992 |
Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
Topics: Adult; Belgium; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hydrogen; Levonorgestrel; Lipids; Magnetic Resonance Spectroscopy; Middle Aged; Military Personnel; Norethindrone; Norgestrel; Progestins; Protons; Regression Analysis; Water | 1991 |
Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Biopsy; Chromatography, High Pressure Liquid; Contraceptive Agents; Contraceptive Devices, Female; Dinoprostone; Endometrium; Female; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Levonorgestrel; Norgestrel; Prostaglandins; Thromboxane B2 | 1991 |
Carbohydrate metabolic studies in women using a levonorgestrel/ethinyl estradiol containing triphasic oral contraceptive for eighteen months.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel | 1991 |
[Influence of vehicles on human skin permeation of norgestrel and levonorgestrel in vitro].
Topics: Adult; Ethanol; Female; Humans; In Vitro Techniques; Levonorgestrel; Male; Norgestrel; Oleic Acid; Oleic Acids; Pharmaceutical Vehicles; Skin Absorption | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Quantitation of hormone replacement induced withdrawal bleeds.
Topics: Adult; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Norgestrel | 1991 |
The significance of bleeding patterns in Norplant implant users.
Topics: Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Pregnancy; Time Factors | 1991 |
From the Food and Drug Administration.
Topics: Contraceptive Agents, Female; Cyanides; Drug Implants; Drug Labeling; Heart Valve Prosthesis; Humans; Levonorgestrel; Nitroprusside; Norgestrel; Prosthesis Failure; United States; United States Food and Drug Administration | 1991 |
A subdermal progestin implant for long-term contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1991 |
A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Topics: Adult; Female; Flurbiprofen; Hemoglobins; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norgestrel; Tranexamic Acid | 1991 |
Characteristics of ovarian follicular development in Norplant users.
Topics: Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Osmolar Concentration; Ovarian Follicle; Progesterone; Reference Values | 1991 |
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Endometrium; Energy Intake; Estradiol; Estradiol Dehydrogenases; Female; Isocitrate Dehydrogenase; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Ovariectomy; Rabbits | 1991 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease | 1991 |
Influence of oral contraceptives on body temperature.
Topics: Adult; Body Temperature; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Norgestrel | 1991 |
Association between contraceptive method accepted and perception of information received: a comparison of Norplant and IUD acceptors.
Topics: Contraception; Contraceptives, Oral, Combined; Counseling; Drug Implants; Female; Humans; Intelligence; Intrauterine Devices; Levonorgestrel; Norgestrel; Patient Education as Topic; Physician-Patient Relations; Socioeconomic Factors | 1991 |
Obstetrics and gynecology.
Topics: Contraceptive Agents, Female; Female; Fertilization in Vitro; Gynecology; Humans; Infant, Newborn; Levonorgestrel; Norgestrel; Obstetrics; Pregnancy; Respiratory Distress Syndrome, Newborn | 1991 |
Norplant: a new contraceptive.
Topics: Anesthesia, Local; Arm; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Patient Education as Topic; Teaching Materials | 1991 |
Contraceptive implants.
Topics: Adolescent; Adult; Capsules; Cervix Mucus; Contraceptive Agents, Female; Drug Implants; Equipment Design; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Progestins; Risk Factors | 1991 |
Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Topics: Adult; Anovulation; Case-Control Studies; Contraceptives, Oral, Combined; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Progesterone; Prospective Studies | 1991 |
[Levonorgestrel-releasing subcutaneous implants. First year's experience].
Topics: Adult; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Patient Compliance; Skin | 1991 |
A subdermal progestin implant for long-term contraception. The Medical Letter.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1991 |
Norplant implants: the mechanism of contraceptive action.
Topics: Chorionic Gonadotropin; Contraceptives, Oral, Combined; Female; Fertilization; Humans; Immunoenzyme Techniques; Levonorgestrel; Luteal Phase; Luteinizing Hormone; Norgestrel; Progesterone | 1991 |
Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Progesterone; Sex Hormone-Binding Globulin | 1991 |
Endometrial vascular features prior to and following exposure to levonorgestrel.
Topics: Arterioles; Blood Coagulation; Blood Vessels; Capillaries; Contraceptive Agents, Female; Contraceptive Devices, Female; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Mast Cells; Menstruation; Norgestrel; Progesterone; Tissue Plasminogen Activator; Veins | 1991 |
Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women.
Topics: Acetylglucosaminidase; Acid Phosphatase; Adult; alpha-L-Fucosidase; alpha-Mannosidase; Contraceptive Agents, Female; Contraceptive Devices, Female; DNA; Endometrium; Female; Humans; L-Lactate Dehydrogenase; Levonorgestrel; Lysosomes; Mannosidases; Norgestrel; Organ Culture Techniques; Proteins | 1991 |
New contraceptive causes controversy.
Topics: Contraceptive Agents, Female; Drug Implants; Humans; Jurisprudence; Levonorgestrel; Norgestrel; Ohio; Stereoisomerism | 1991 |
Dynamic changes of myometrial activity, levels of PGF2 alpha and E2 in rabbits after insertion of four types of IUDs.
Topics: Animals; Contraceptive Agents, Female; Dinoprost; Electrophysiology; Estradiol; Female; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Myometrium; Norgestrel; Rabbits; Uterine Contraction | 1991 |
Short-term and long-term effects of Norplant-2 on plasma lipoproteins and glucose tolerance.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Longitudinal Studies; Norgestrel; Transaminases; Triglycerides | 1991 |
Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants.
Topics: Amenorrhea; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Oligomenorrhea; Progesterone | 1991 |
Factors associated with the acceptance of Norplant or IUD among women with similar socio-demographic characteristics.
Topics: Adult; Contraception; Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Marriage; Norgestrel; Patient Acceptance of Health Care; Socioeconomic Factors | 1991 |
Contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1991 |
Changes in carbohydrate metabolism during 30 months on Norplant.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Drug Implants; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Time Factors | 1991 |
Effects of oral contraceptive pills on serum lipoproteins and triglycerides.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Regression Analysis; Time Factors; Triglycerides | 1990 |
Attitudes towards contraceptive implants and injectables among present and former users in Singapore.
Topics: Adult; Aniline Compounds; Capsules; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Humans; Injections, Intradermal; Levonorgestrel; Middle Aged; Norgestrel; Singapore | 1990 |
Insertion site complications during the first year of NORPLANT use.
Topics: Adult; Contraceptive Agents, Female; Demography; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Norgestrel; Vaginitis | 1990 |
Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Topics: Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Luteal Phase; Norgestrel; Ovary; Progesterone | 1990 |
[Norplant].
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1990 |
[Norplant in The Netherlands].
Topics: Adolescent; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel | 1990 |
Persisting cyclical uterine bleeding in patients treated with radical radiation therapy and hormonal replacement for carcinoma of the cervix.
Topics: Adult; Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Ovary; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1990 |
Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
Topics: Animals; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Glucose; Hindlimb; Insulin; Insulin Antagonists; Insulin Resistance; Levonorgestrel; Muscles; Norethindrone; Norgestrel; Phenylalanine; Progesterone Congeners; Rats; Rats, Inbred Strains | 1990 |
A model to detect interactions between roxithromycin and oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Norgestrel; Roxithromycin | 1990 |
A three-year clinical evaluation of Norplant in Singaporean acceptors.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Singapore; Uterine Hemorrhage | 1990 |
A three-year evaluation of metabolic changes in Singaporean Norplant acceptors.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Glucose Tolerance Test; Humans; Levonorgestrel; Lipid Metabolism; Liver; Longitudinal Studies; Norgestrel; Singapore | 1990 |
A three-year evaluation of hemostatic function in Singaporean Norplant acceptors.
Topics: Blood Coagulation Factors; Blood Platelets; Contraceptive Agents, Female; Drug Implants; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Thrombosis | 1990 |
[Norplant].
Topics: Contraceptives, Oral, Combined; Developing Countries; Drug Implants; Family Planning Services; Female; Humans; Levonorgestrel; Norgestrel | 1990 |
Clinical results with subcutaneous implants containing 3-keto desogestrel.
Topics: Binding, Competitive; Contraceptives, Oral, Combined; Desogestrel; Dihydrotestosterone; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Ovarian function during use of a levonorgestrel-releasing IUD.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Follicular Cyst; Gonadotropins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Ovary; Progesterone; Sex Hormone-Binding Globulin; Sperm-Ovum Interactions; Ultrasonography | 1990 |
Management of menorrhagia.
Topics: Contraceptive Agents, Female; Costs and Cost Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norgestrel; United Kingdom | 1990 |
Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
Topics: Adult; Consumer Behavior; Contraceptive Agents, Female; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norgestrel; Prognosis; Quality of Life; Time Factors | 1990 |
A three-year clinical evaluation of Norplant-2 rods in Singapore.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Patient Compliance; Singapore | 1990 |
A three-year evaluation of metabolic changes in Singaporean Norplant-2 rod acceptors.
Topics: Bilirubin; Carbohydrate Metabolism; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Lipid Metabolism; Liver; Longitudinal Studies; Norgestrel; Singapore | 1990 |
A three-year evaluation of hemostatic function in Singaporean Norplant-2 rod acceptors.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Partial Thromboplastin Time; Prothrombin Time; Singapore; Thromboembolism | 1990 |
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Contraceptive vaginal ring--a rising star on the contraceptive horizon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Patient Compliance | 1990 |
Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
Topics: Adult; Contraceptives, Oral; Female; Half-Life; Humans; Japan; Levonorgestrel; Metabolic Clearance Rate; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Clinical experience with the progestogen-only pill.
Topics: Adult; Contraception; Contraceptives, Oral, Combined; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Dropouts; Progestins | 1990 |
The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
Topics: Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lynestrenol; Mestranol; Norethindrone; Norgestrel | 1990 |
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
Topics: Adolescent; Adult; Carbamazepine; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Phenytoin | 1990 |
In vitro evaluations of transdermal levonorgestrel.
Topics: Acetates; Administration, Cutaneous; Animals; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Diffusion; Guinea Pigs; In Vitro Techniques; Levonorgestrel; Membranes, Artificial; Mice; Mice, Hairless; Norgestrel; Rats | 1990 |
Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Gonadotropins; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovary; Periodicity; Placebos | 1990 |
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats | 1990 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1990 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Altered growth hormone secretion during oral contraception.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pituitary Gland, Anterior; Progesterone Congeners | 1990 |
Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats.
Topics: Animals; Binding, Competitive; Blood Pressure; Ethinyl Estradiol; Female; Heart; Hypertension; Iodocyanopindolol; Kidney; Levonorgestrel; Norgestrel; Pindolol; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
[The levonorgestrel intrauterine device].
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstrual Cycle; Norgestrel; Uterine Hemorrhage | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: metabolic changes.
Topics: Bilirubin; Carbohydrate Metabolism; Cholesterol; Female; Humans; Levonorgestrel; Lipid Metabolism; Liver; Liver Function Tests; Longitudinal Studies; Norgestrel; Singapore; Triglycerides | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: haemostatic changes.
Topics: Blood Coagulation; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Platelet Aggregation; Platelet Count; Singapore; Thrombosis | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: metabolic changes.
Topics: Bilirubin; Carbohydrate Metabolism; Cholesterol; Female; Humans; Levonorgestrel; Lipid Metabolism; Liver; Longitudinal Studies; Norgestrel; Singapore; Triglycerides | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: haemostatic changes.
Topics: Blood Coagulation; Female; Fibrinogen; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Platelet Aggregation; Platelet Count; Singapore; Thrombosis | 1989 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
Topics: Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Patient Compliance; Pelvic Inflammatory Disease; Pregnancy | 1989 |
Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
Topics: Adult; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Ovarian Follicle; Ovary; Ovulation; Progesterone; Time Factors | 1989 |
Risk factors for acute myocardial infarction in women.
Topics: Acute Disease; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Myocardial Infarction; Norgestrel; Risk Factors | 1989 |
Effect of Norplant contraceptive use on hemoglobin, packed cell volume and menstrual bleeding patterns.
Topics: Adult; Blood Volume; Female; Follow-Up Studies; Hemoglobins; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel | 1989 |
Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Topics: Adult; Ceruloplasmin; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin | 1989 |
Bleeding patterns and acceptability among Norplant users in two Asian countries.
Topics: Adult; Contraceptives, Oral, Combined; Demography; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation; Norgestrel; Philippines; Sri Lanka; Stereoisomerism | 1989 |
Hepatic actions of levonorgestrel: correlations between biochemical and morphological findings.
Topics: Animals; Contraceptives, Oral, Combined; Cytochrome P-450 Enzyme System; Glutathione; Levonorgestrel; Liver; Male; Microscopy, Electron; Mitochondria, Liver; Norgestrel; Rats; Rats, Inbred Strains | 1989 |
Transdermal delivery of levonorgestrel. IV: Evaluation of membranes.
Topics: Acetates; Administration, Cutaneous; Animals; Chromatography, High Pressure Liquid; Contraceptives, Oral, Combined; Ethanol; Evaluation Studies as Topic; In Vitro Techniques; Levonorgestrel; Membranes, Artificial; Norgestrel; Rats; Skin Absorption | 1989 |
Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
Topics: Adult; Contraceptives, Oral; Dinoprost; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lypressin; Menstrual Cycle; Norgestrel; Pressure; Uterine Contraction; Uterus | 1989 |
Transdermal delivery of levonorgestrel. VII. In vivo studies.
Topics: Administration, Cutaneous; Animals; Female; Infusion Pumps; Levonorgestrel; Norgestrel; Rabbits; Stereoisomerism; Time Factors | 1989 |
Estradiol is a potent inhibitor of the hypotriglyceridemic effect of levonorgestrel in female rats.
Topics: Animals; Cholesterol; Estradiol; Female; Levonorgestrel; Norgestrel; Rats; Triglycerides | 1989 |
Norplant contraceptive subdermal implants: two-year experience in Singapore.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Singapore | 1989 |
Radioimmunological determination of levonorgestrel and ethinylestradiol.
Topics: Animals; Contraceptive Agents, Female; Female; Haplorhini; Immune Sera; Levonorgestrel; Liver; Lynestrenol; Norgestrel; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains | 1989 |
Fertility control in female white-tailed deer.
Topics: Animals; Contraception; Contraceptive Agents, Female; Deer; Drug Implants; Female; Fertility; Labor, Obstetric; Levonorgestrel; Melengestrol Acetate; Norgestrel; Pregnadienes; Pregnancy | 1989 |
Possible estrogen-induced NMS.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Neuroleptic Malignant Syndrome; Norgestrel; Schizophrenia, Paranoid | 1989 |
A longitudinal study on cortisol, prolactin and thyroid hormones in users of Norplant subdermal implants or a copper T device.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Hydrocortisone; Intrauterine Devices, Copper; Levonorgestrel; Longitudinal Studies; Norgestrel; Prolactin; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 1989 |
[Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Topics: Adult; Anticoagulants; Arteriovenous Shunt, Surgical; Budd-Chiari Syndrome; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Male; Norgestrel; Polycythemia Vera; Radiography | 1989 |
Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro.
Topics: Acetates; Administration, Cutaneous; Animals; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Ethanol; In Vitro Techniques; Levonorgestrel; Norgestrel; Permeability; Rats; Skin Absorption | 1989 |
Norplant-2 rods contraceptive subdermal implants: two-year experience in Singapore.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Silicone Elastomers; Singapore | 1989 |
Bleeding patterns and acceptability among Norplant users in Singapore.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Singapore | 1989 |
The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.
Topics: Adult; Cytophotometry; DNA; Endometrium; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norgestrel; Stainless Steel | 1989 |
[Initial experiences with a levonorgestrel-ethinyl estradiol combination for interception].
Topics: Adolescent; Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Pregnancy; Progesterone; Prospective Studies | 1989 |
Correlation of contraceptive activity of norethisterone and levonorgestrel esters with VR(w) values and hydrolysis rates.
Topics: Acetic Anhydrides; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Esterification; Esters; Fluoroacetates; Hydrolysis; Levonorgestrel; Norethindrone; Norgestrel; Regression Analysis; Solubility; Sulfur Oxides; Thermodynamics | 1989 |
Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.
Topics: Adhesives; Administration, Cutaneous; Animals; Biological Availability; Contraceptive Agents, Female; Drug Combinations; Drug Evaluation; Drug Stability; Estradiol; Female; Humans; In Vitro Techniques; Irritants; Levonorgestrel; Mice; Mice, Hairless; Myristates; Norgestrel; Rabbits; Skin Absorption; Skin Diseases | 1989 |
Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women.
Topics: Administration, Intravaginal; Bone and Bones; Bone Density; Bone Resorption; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Norgestrel; Pessaries | 1989 |
Potential acceptors of Norplant implants in comparison with recently sterilized women in Sri Lanka.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Norgestrel; Patient Acceptance of Health Care; Socioeconomic Factors; Sri Lanka; Sterilization, Tubal | 1989 |
[Long-term follow-up of women treated with contraceptive implants of levonorgestrel Norplant].
Topics: Adult; Contraceptives, Oral, Combined; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Contraceptives: a look at the future.
Topics: Abortifacient Agents; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Female; Forecasting; Humans; Injections; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel; Pregnancy | 1989 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
Topics: Arm; Capsules; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Norgestrel; Silicone Elastomers; Time Factors; Ultrasonography | 1985 |
The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
Topics: Adult; Anemia, Hypochromic; Contraceptive Agents, Female; Female; Ferritins; Hematocrit; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Norgestrel | 1988 |
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism | 1987 |
Effect of levonorgestrel and ethinyloestradiol on vasoconstriction in rat isolated vasculature.
Topics: Angiotensin II; Animals; Blood Pressure; Clonidine; Contraceptive Agents, Female; Ethinyl Estradiol; Female; In Vitro Techniques; Levonorgestrel; Norepinephrine; Norgestrel; Phenylephrine; Rats; Rats, Inbred Strains; Splanchnic Circulation; Vasoconstriction | 1988 |
[Lipid metabolism in hormonal contraception].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Levonorgestrel; Lipid Metabolism; Norethindrone; Norgestrel; Time Factors | 1985 |
Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1986 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Androgen levels in women using Norplant implants.
Topics: Acne Vulgaris; Adult; Androgens; Androstenedione; Circadian Rhythm; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation | 1987 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cholesterol, HDL; Contraceptives, Oral; Desogestrel; Epoprostenol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes; Thromboxane A2; Thromboxane B2 | 1987 |
[Impetigo herpetiformis].
Topics: Adult; Biopsy; Contraceptives, Oral, Combined; Cysts; Dermatitis Herpetiformis; Drug Eruptions; Ethinyl Estradiol; Etretinate; Female; HLA Antigens; HLA-C Antigens; Humans; Impetigo; Levonorgestrel; Norgestrel; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Skin; Splenic Rupture | 1988 |
Trace elements during 2 years' oral contraception with low-estrogen preparations.
Topics: Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Levonorgestrel; Norgestrel; Norpregnenes; Trace Elements; Zinc | 1988 |
Progestagen-dependent effect on some plasma proteins during oral contraception.
Topics: Blood Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Sex Hormone-Binding Globulin; Transcortin | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Topics: Abortion, Induced; Administration, Intravaginal; Adult; Age Factors; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norgestrel; Parity; Pregnancy; Time Factors | 1988 |
Comparative effects of combined oral contraceptives containing desogestrel or levonorgestrel on serum lipids, lipoproteins and sex hormone binding globulin in healthy women.
Topics: Adult; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation; Sex Hormone-Binding Globulin; Triglycerides | 1988 |
Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel.
Topics: Adolescent; Adult; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Fertility; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Saliva; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.
Topics: Adult; Apomorphine; Arousal; Blood Pressure; Brain; Clonidine; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1985 |
Ovarian function during oestrogen-progestin replacement treatment in pre-menopausal women.
Topics: Adult; Estradiol; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Menopause; Menstrual Cycle; Middle Aged; Norgestrel; Ovary; Progesterone; Stereoisomerism; Ultrasonics | 1986 |
Chronic steroid contraceptive treatment decreases renal alpha-adrenoceptor levels in the rat.
Topics: Animals; Ethinyl Estradiol; Female; Hypertension, Renal; Kidney; Levonorgestrel; Norgestrel; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1986 |
Liver-cell adenoma. Case report.
Topics: Adult; Carcinoma, Hepatocellular; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Neoplasms; Norgestrel; Radionuclide Imaging | 1986 |
Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.
Topics: Animals; Contraceptive Agents, Female; Decidua; Drug Combinations; Drug Implants; Endometrium; Estradiol; Female; Hydatidiform Mole, Invasive; Levonorgestrel; Male; Mice; Mice, Nude; Microscopy, Electron; Norgestrel; Ovary; Polyps; Pregnancy; Rabbits; Silicone Elastomers; Spleen; Uterine Neoplasms; Uterus | 1987 |
Influence of pregnancy, oophorectomy and contraceptive steroids on gall bladder concentrating function and hepatic bile flow in the cat.
Topics: Absorption; Animals; Bile; Body Water; Cats; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Gallbladder; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Pregnancy; Pregnancy, Animal; Prolactin; Stereoisomerism | 1986 |
The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.
Topics: Adolescent; Adult; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Valproic Acid | 1986 |
Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
Topics: Adult; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteal Phase; Luteinizing Hormone; Norgestrel; Ovulation; Progesterone; Sterilization, Tubal | 1986 |
Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
Topics: Adult; Antacids; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Time Factors | 1986 |
Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
Topics: Adolescent; Adult; Angiotensinogen; Antithrombin III; Blood Pressure; Contraceptive Agents, Female; Contraceptive Devices, Female; Estradiol; Evaluation Studies as Topic; Female; Humans; Hypertension; Leukorrhea; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Prospective Studies; Sex Hormone-Binding Globulin | 1986 |
A prospective study of the metabolic effects of a low dose combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prospective Studies | 1986 |
Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
Topics: Adult; Drug Interactions; Epilepsy; Female; Humans; Kinetics; Levonorgestrel; Menstruation; Norgestrel; Ovulation; Phenytoin; Pregnancy; Sex Hormone-Binding Globulin | 1986 |
Bioavailability of levonorgestrel from intravaginal rings in women of low income groups.
Topics: Adolescent; Adult; Biological Availability; Female; Half-Life; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Nutrition Disorders; Progesterone; Socioeconomic Factors; Vagina | 1986 |
Oral contraception, 1986. Currently available formulations.
Topics: Canada; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Drug Compounding; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; United States | 1986 |
Bleeding pattern, outcome of accidental pregnancies and levonorgestrel plasma levels associated with method failure in Norplant implants users.
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Levonorgestrel; Male; Menstruation; Norgestrel; Pregnancy; Pregnancy, Ectopic | 1986 |
Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant, by nursing mothers.
Topics: Breast Feeding; Drug Implants; Female; Humans; Infant; Levonorgestrel; Norgestrel | 1986 |
Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs.
Topics: Adolescent; Adult; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Praziquantel; Schistosomiasis; Schistosomicides; Trichlorfon | 1986 |
Pharmacokinetic studies with a vaginal delivery system releasing levonorgestrel at a near zero order rate for one year.
Topics: Administration, Intravaginal; Contraceptive Devices, Female; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin; Uterine Hemorrhage | 1986 |
Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
Topics: Adolescent; Adult; Atrophy; Endometrium; Female; Humans; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Necrosis; Norgestrel; Time Factors | 1986 |
Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Topics: Adult; Anticonvulsants; Drug Implants; Drug Interactions; Epilepsy; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy | 1986 |
Effects of oral contraceptives on carbohydrate metabolism.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norethindrone; Norgestrel | 1986 |
Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis.
Topics: Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Norgestrel | 1986 |
Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed
Topics: Administration, Oral; Adult; Breast Feeding; Female; Follicle Stimulating Hormone; Humans; Infant; Infant, Newborn; Injections, Intradermal; Kinetics; Lactation; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Pregnancy; Testosterone | 1986 |
Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Infusion Pumps; Levonorgestrel; Luteinizing Hormone; Macaca mulatta; Menstrual Cycle; Monkey Diseases; Norgestrel; Progesterone | 1986 |
Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Cell Line; Estradiol; Female; Humans; Interphase; Levonorgestrel; Norgestrel; Tamoxifen; Tetradecanoylphorbol Acetate | 1987 |
Evaluation of a new triphasic oral contraceptive in private practice.
Topics: Blood Glucose; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Menstrual Cycle; Norgestrel; Private Practice | 1986 |
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Effects of levonorgestrel on enzymes responsible for synthesis of triacylglycerols in rat liver.
Topics: Animals; Female; Glycerol-3-Phosphate O-Acyltransferase; Glycerophosphates; Levonorgestrel; Liver; Norgestrel; Phosphatidate Phosphatase; Rats; Rats, Inbred Strains; Subcellular Fractions; Triglycerides | 1987 |
Aspects of thyroid function during use of Norplant implants.
Topics: Adult; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Radioimmunoassay; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1986 |
A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.
Topics: Administration, Oral; Adult; Arteries; Endometrium; Female; Humans; Levonorgestrel; Middle Aged; Myometrium; Norethindrone; Norgestrel; Progesterone; Veins | 1986 |
One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Topics: Adult; Antipyrine; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metabolic Clearance Rate; Microsomes, Liver; Norgestrel; Triglycerides | 1987 |
Clinical evaluation of drugs used in fertility regulation.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Drug Evaluation; Humans; Levonorgestrel; Norgestrel | 1986 |
Contraceptive steroid treatment affects steroid binding proteins and the percentage of free 17 beta-estradiol and testosterone in the cynomolgus monkey (Macaca fascicularis).
Topics: Administration, Oral; Animals; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Levonorgestrel; Macaca fascicularis; Male; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Vagina | 1987 |
Effect of Norplant on mothers and infants in the postpartum period.
Topics: Adult; Child Development; Contraceptive Agents, Female; Female; Humans; Infant; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Norgestrel; Pregnancy | 1986 |
Serum levels of cholesterol and lipoproteins in rhesus monkeys: comparison of the effect of gonadotropin-releasing hormone agonist and the progestin, levonorgestrel.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Endometriosis; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Lipoproteins; Lipoproteins, VLDL; Macaca mulatta; Norgestrel; Uterine Neoplasms | 1987 |
Effect of the hormonal contraception on serum reverse triiodothyronine levels.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stimulation, Chemical; Thyroid Hormones; Thyroxine-Binding Proteins; Triiodothyronine, Reverse | 1987 |
Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Plasminogen; Proteins; Sex Hormone-Binding Globulin; Tissue Plasminogen Activator; von Willebrand Factor | 1987 |
[Norplant--a subdermal contraceptive implant].
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel | 1986 |
The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Drug Interactions; Female; Humans; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin | 1987 |
Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Ferritins; Hematocrit; Humans; Levonorgestrel; Menstruation; Norgestrel; Time Factors | 1987 |
Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques.
Topics: Animals; Arteriosclerosis; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Coronary Artery Disease; Estradiol; Female; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL2; Macaca fascicularis; Male; Norgestrel | 1987 |
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints.
Topics: Administration, Cutaneous; Administration, Oral; Cell Division; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Norgestrel | 1987 |
[Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dietary Carbohydrates; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel | 1987 |
Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
Topics: Acetaminophen; Adult; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel | 1987 |
Ovulation detection following removal of levonorgestrel subdermal contraceptive implants.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Norgestrel; Ovulation Detection; Progesterone; Time Factors | 1987 |
Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
Topics: Adult; Biological Availability; Cystic Fibrosis; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Stereoisomerism | 1987 |
Plasma levels of cortisol and corticosteroid binding globulin during use of Norplant-2 implants.
Topics: Adult; Delayed-Action Preparations; Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norgestrel; Transcortin | 1987 |
Chinical experience with levonorgestrel and ethinyl estradiol in Beijing.
Topics: Adult; China; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1987 |
Five-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage | 1987 |
Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs.
Topics: Age Factors; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pregnancy; Probability; Time Factors | 1987 |
Direct measurements of enterohepatic circulation of bile acids in the cat. Influence of contraceptive steroids and oophorectomy.
Topics: Animals; Bile Acids and Salts; Cats; Contraceptives, Oral, Combined; Enterohepatic Circulation; Ethinyl Estradiol; Female; Levonorgestrel; Norgestrel; Ovariectomy | 1987 |
The future of intrauterine contraception.
Topics: Adolescent; Adult; Contraceptives, Oral; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norgestrel; Research; Risk Factors | 1987 |
Progestogen potency in oral contraceptive pills.
Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Phasic approach to oral contraceptives.
Topics: Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Norgestrel; Progesterone | 1987 |
Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Task Force on Post-ovulatory Methods for Fertility Regulation.
Topics: Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Evaluation; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovulation; Pregnancy | 1987 |
Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel; Smoking | 1988 |
[Norplant as a contraceptive seen from the midwife's viewpoint].
Topics: Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1987 |
Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Male; Menstrual Cycle; Norgestrel; Progesterone; Sperm Motility; Spermatozoa | 1987 |
Pregnancy after removal of Norplant implants contraceptive.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy | 1987 |
Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Topics: Adult; Chorion; Chorionic Gonadotropin; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel | 1987 |
Chorea associated with oral contraception.
Topics: Adolescent; Adult; Chorea; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1987 |
Reduced incidence of rabbit endometrial neoplasia with levonorgestrel implant.
Topics: Animals; Biopsy; Dimethylpolysiloxanes; Drug Implants; Female; Levonorgestrel; Norgestrel; Rabbits; Random Allocation; Uterine Neoplasms | 1988 |
Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
Topics: Adolescent; Adult; Arginine Vasopressin; Contraceptives, Oral, Combined; Dinoprost; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prostaglandins F | 1987 |
Biodegradable hollow fibres for the controlled release of drugs.
Topics: Animals; Biodegradation, Environmental; Collagen; Delayed-Action Preparations; Disinfection; Drug Carriers; Drug Implants; Female; Fibroblasts; Foreign-Body Reaction; Granulocytes; Kinetics; Lactates; Lactic Acid; Levonorgestrel; Macrophages; Norgestrel; Polyesters; Polymers; Rats; Tensile Strength | 1988 |
Five-year experience with Norplant.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
Serum lipids in Norplant implants users: a cross-sectional study.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Cross-Sectional Studies; Drug Implants; Female; Humans; Indonesia; Levonorgestrel; Lipids; Norgestrel; Triglycerides | 1987 |
Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Stereoisomerism; Time Factors | 1988 |
The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions.
Topics: Adult; Cognition; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oxytocin; Prolactin; Psychological Tests | 1987 |
Metabolic effects of combined oral contraceptive preparations.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Contraceptives, Oral, Combined; Female; Follicular Phase; Humans; Hydroxybutyrates; Levonorgestrel; Luteal Phase; Norethindrone; Norgestrel | 1987 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Topics: Adult; Carbamazepine; Cervix Uteri; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1987 |
Progestogen regulation of tissue plasminogen activator in a human melanoma cell line.
Topics: Ethanol; Fibrinolysis; Humans; Levonorgestrel; Medroxyprogesterone; Melanoma; Norethindrone; Norgestrel; Osmolar Concentration; Time Factors; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1988 |
Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
Topics: Adult; Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Cirrhosis; Lynestrenol; Norgestrel; Peliosis Hepatis; Radiography; Time Factors | 1988 |
Effect of 24 mm levonorgestrel IUD on uterine endometrium of female rhesus monkeys, Macaca mulatta.
Topics: Animals; Endometrium; Female; Intrauterine Devices; Levonorgestrel; Macaca mulatta; Microscopy, Electron, Scanning; Norgestrel; Uterus | 1988 |
Pharmacokinetic study of levonorgestrel used as a postcoital agent.
Topics: Absorption; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Estradiol; Female; Follicle Stimulating Hormone; Half-Life; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Progesterone; Prolactin | 1988 |
Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, VLDL; Norgestrel; Triglycerides | 1988 |
[Evaluation of the contraceptive agent norplant in the municipality of Rio de Janeiro, RJ (Brazil)].
Topics: Administration, Oral; Adolescent; Adult; Blood Pressure; Body Weight; Evaluation Studies as Topic; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Norgestrel; Parity; Product Surveillance, Postmarketing | 1987 |
Effective interception with the levonorgestrel-20-IUD contrarily to WHO advocated Lng-2-microdose IUD.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; World Health Organization | 1988 |
Norplant contraceptive subdermal implants: one year experience in Singapore.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Drug Evaluation; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Singapore | 1988 |
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.
Topics: Administration, Oral; Bone and Bones; Cross-Sectional Studies; Estradiol; Estrogens; Female; Humans; Hydroxyapatites; Injections, Subcutaneous; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Osteoporosis; Testosterone | 1988 |
The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
Topics: Adult; Bilirubin; Blood Glucose; Blood Proteins; Cholesterol; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Longitudinal Studies; Norgestrel; Singapore; Time Factors; Triglycerides | 1988 |
The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changes.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Female; Hematocrit; Hemoglobins; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Prothrombin Time | 1988 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
Patterns of bleeding and body iron stores during the use of a levonorgestrel-releasing intracervical device.
Topics: Adolescent; Adult; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norgestrel | 1988 |
Effect of food-restriction on steady state kinetics and tissue distribution of norethindrone and levonorgestrel in rabbits.
Topics: Animals; Body Weight; Female; Food Deprivation; Levonorgestrel; Metabolic Clearance Rate; Norethindrone; Norgestrel; Organ Size; Rabbits; Tissue Distribution | 1988 |
[A comparative study on the antifertility action of levonorgestrel oxime and levonorgestrel].
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Combinations; Embryo Implantation; Endometrium; Female; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism | 1988 |
[Comparison of the effect of various dosages of anordrin and levonorgestrel on the pituitary responsiveness to GnRH].
Topics: Animals; Contraceptive Agents, Female; Female; Levonorgestrel; Luteinizing Hormone; Norandrostanes; Norgestrel; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Rats; Rats, Inbred Strains | 1988 |
Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants.
Topics: Adult; Body Composition; Body Weight; Delayed-Action Preparations; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1988 |
Norplant-2 rods: one year experience in Singapore.
Topics: Adult; Arm; Consumer Behavior; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Singapore | 1988 |
The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: haemostatic changes.
Topics: Adult; Blood Coagulation; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Prothrombin Time; Singapore | 1988 |
The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
Topics: Adult; Bilirubin; Cholesterol; Female; Glucose Tolerance Test; Humans; Levonorgestrel; Lipids; Liver; Norgestrel; Singapore | 1988 |
Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
Topics: Adult; Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Ovulation; Progesterone | 1988 |
Effect of addition oral contraceptives in chicks diet.
Topics: Adipose Tissue; Animal Feed; Animals; Blood Glucose; Blood Proteins; Chickens; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Levonorgestrel; Liver; Norgestrel; Organ Size; Weight Gain | 1988 |
A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China.
Topics: Adolescent; Adult; Cardiovascular System; China; Contraceptive Agents, Female; Drug Evaluation, Preclinical; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Platelet Count; Pregnancy | 1988 |
Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy | 1988 |
Automated stability-indicating high-performance liquid chromatographic assay for ethinyl estradiol and (levo)norgestrel tablets.
Topics: Automation; Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Drug Stability; Ethinyl Estradiol; Levonorgestrel; Norgestrel; Reproducibility of Results; Solutions; Tablets | 1987 |
Does endogenous sex hormone binding globulin influence the contraceptive effect of levonorgestrel?
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin | 1988 |
"Free levonorgestrel index" (FLI) is a better parameter than plasma level of levonorgestrel for predicting risk of pregnancy during use of subdermal contraceptive implants releasing levonorgestrel.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Norgestrel; Predictive Value of Tests; Pregnancy; Risk Factors | 1988 |
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Topics: Adult; Castration; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norgestrel; Norpregnenes | 1985 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Topics: Absorption; Adult; Cervix Mucus; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Drug Evaluation; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Uterine Hemorrhage | 1985 |
Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy.
Topics: Adult; Colectomy; Colitis, Ulcerative; Contraceptives, Oral, Combined; Female; Humans; Ileostomy; Intestinal Absorption; Kinetics; Levonorgestrel; Norgestrel; Postoperative Complications | 1985 |
[Chromosome analysis of female baboons following treatment with STS 557 and levonorgestrel].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Nandrolone; Norgestrel; Papio; Progesterone Congeners; Stereoisomerism | 1985 |
Long-term experience with Norplant contraceptive implants in Finland.
Topics: Adult; Contraception; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel | 1985 |
Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants.
Topics: Anovulation; Cervix Mucus; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Luteal Phase; Male; Norgestrel; Progesterone; Sperm Transport | 1985 |
[Microval].
Topics: Contraceptives, Oral, Combined; Drug Interactions; Female; Humans; Levonorgestrel; Norgestrel | 1985 |
Clinical chemistry in women treated with six levonorgestrel covered rods or with a copper IUD.
Topics: Adolescent; Adult; Blood Chemical Analysis; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Hormones; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Norgestrel | 1985 |
The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in women.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Function Tests; Sex Hormone-Binding Globulin; Vagina | 1985 |
Controlled drug release from poly(ortho esters).
Topics: Anhydrides; Animals; Biodegradation, Environmental; Contraceptives, Oral, Combined; Delayed-Action Preparations; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Lactates; Lactic Acid; Levonorgestrel; Microscopy, Electron, Scanning; Norgestrel; Polyesters; Rabbits | 1985 |
Effects of antifertility estrogens and progestins on the endometrial surface of early pregnant rats. A scanning electron microscopic study.
Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Estriol; Estrogens; Female; Levonorgestrel; Mestranol; Microscopy, Electron, Scanning; Microvilli; Nandrolone; Norgestrel; Pregnancy; Pregnancy, Animal; Progestins; Rats; Rats, Inbred Strains | 1985 |
Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
Topics: Animals; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Levonorgestrel; Lipids; Norgestrel; Rats | 1985 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Humans; Levonorgestrel; Lipids; Menopause; Middle Aged; Norgestrel | 1985 |
Facts about an implantable contraceptive: memorandum from a WHO meeting.
Topics: Animals; Contraceptive Agents; Contraceptives, Oral, Combined; Drug Implants; Female; Genitalia, Female; Humans; Levonorgestrel; Norgestrel; Reproduction; Silicone Elastomers | 1985 |
Poly(ortho ester) biodegradable polymer systems.
Topics: Anhydrides; Biodegradation, Environmental; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Kinetics; Levonorgestrel; Methods; Norethindrone; Norgestrel; Polyesters; Solubility | 1985 |
Effect of cyclic estradiol valerate/levonorgestrel on periclimacteric syndrome and endometrial cytology.
Topics: Climacteric; Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1985 |
Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1985 |
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions.
Topics: Breast Neoplasms; Cell Count; Cell Division; Cell Line; Culture Media; Drug Interactions; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Tamoxifen; Thymidine; Tritium | 1985 |
Effect of two different combinations of ethinyl estradiol and levonorgestrel on hepatic functions.
Topics: Animals; Drug Interactions; Ethinyl Estradiol; Female; Levonorgestrel; Liver; Norgestrel; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants.
Topics: Adult; Breast Feeding; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Infant; Infant, Newborn; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy | 1985 |
The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterus.
Topics: Animals; Binding, Competitive; Chromatography, High Pressure Liquid; Endometrium; Female; Levonorgestrel; Norgestrel; Progesterone; Rabbits; Receptors, Progesterone; Uterus | 1985 |
Pharmacokinetics of norethisterone and levonorgestrel in experimental iron deficiency anemia in rabbits.
Topics: Anemia, Hypochromic; Animals; Biological Availability; Female; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Rabbits | 1985 |
[Concerning an implantable contraceptive: a memorandum of a WHO meeting].
Topics: Drug Implants; Female; Genitalia, Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism; World Health Organization | 1985 |
Measurement of ethynylestradiol and levonorgestrel incorporated into sustained release contraceptive formulations.
Topics: Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Levonorgestrel; Norgestrel; Silicone Elastomers; Stereoisomerism | 1985 |
Norethisterone and levonorgestrel esters: a novel synthetic method.
Topics: Acetic Anhydrides; Esters; Fluoroacetates; Levonorgestrel; Methods; Norethindrone; Norgestrel | 1985 |
Examination of the effect of Anteovin tablet on the endometrium.
Topics: Adult; Drug Combinations; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1985 |
Effect of postcoital contraceptive levonorgestrel (Postinor) on endometrial oestradiol binding.
Topics: Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Endometrium; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Receptors, Estradiol; Receptors, Estrogen | 1985 |
Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel.
Topics: Animals; Drug Compounding; Female; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Levonorgestrel; Microscopy, Electron, Scanning; Microspheres; Norgestrel; Papio; Polymers; Time Factors | 1985 |
[Influence of Norplant contraceptive implants on lactation and infant growth].
Topics: Body Weight; Breast Feeding; Female; Growth; Humans; Infant; Infant, Newborn; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Male; Milk, Human; Norgestrel; Pregnancy | 1985 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders.
Topics: Animals; Biodegradation, Environmental; Drug Implants; Feces; Female; Glycolates; Lactates; Levonorgestrel; Norgestrel; Polymers; Rats; Time Factors | 1980 |
Serum lipids and high-density-lipoprotein cholesterol in women on long-term sustained low-dose IUD treatment with levonorgestrel.
Topics: Adult; Cholesterol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Pregnancy; Stereoisomerism; Triglycerides | 1981 |
Pharmacokinetic and "potency" of contraceptive steroids.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel | 1984 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Progestagenic and antigonadotrophic activities of STS 557.
Topics: Administration, Oral; Animals; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Gonadotropins; Injections, Subcutaneous; Levonorgestrel; Nandrolone; Norethindrone; Norgestrel; Ovulation; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Metyrapone; Norgestrel; Norpregnenes; Progestins; Random Allocation | 1982 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
[Therapeutic trend in acne associated with the menstrual cycle].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1983 |
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Random Allocation; Serum Globulins; Sex Hormone-Binding Globulin; Transcortin | 1983 |
[Non-virilizing hormonal therapy in women with secondary disorders of sexual responsiveness].
Topics: Adult; Clomiphene; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Drug Combinations; Estradiol; Etiocholanolone; Female; Humans; Levonorgestrel; Libido; Male; Mesterolone; Norgestrel; Orgasm; Sexual Dysfunction, Physiological; Testosterone | 1983 |
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1984 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Castration; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Phosphatidylcholines; Progesterone Congeners; Stereoisomerism; Uterine Cervical Neoplasms | 1984 |
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors | 1984 |
Milestones in intrauterine device development.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Equipment Design; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Progesterone | 1983 |
The morning after: novel hormonal approaches to postcoital interception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Gestrinone; Humans; Levonorgestrel; Luteolytic Agents; Male; Norgestrel; Receptors, Progesterone | 1983 |
The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.
Topics: Biodegradation, Environmental; Body Temperature; Capsules; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Estrogens; Female; Gonadotropins; Humans; Levonorgestrel; Norgestrel; Ovulation; Progesterone | 1983 |
Binding of levonorgestrel to monkey plasma proteins.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Combined; Dihydrotestosterone; Estradiol; Female; Levonorgestrel; Macaca mulatta; Norgestrel; Sex Hormone-Binding Globulin; Testosterone | 1983 |
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
Topics: Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1983 |
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1983 |
A new ultra-low-dose combination oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Stereoisomerism | 1983 |
Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Pharmacokinetics of levonorgestrel in Indian women.
Topics: Adult; Anthropometry; Contraceptives, Oral, Combined; Female; Half-Life; Humans; India; Kinetics; Levonorgestrel; Models, Biological; Norgestrel; Nutritional Physiological Phenomena | 1983 |
Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Topics: Blood Specimen Collection; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Tourniquets | 1983 |
Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Drug Implants; Estradiol; Female; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Lipids; Norgestrel; Phosphorus; Testosterone; Thyroid Hormones; Triglycerides | 1983 |
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage | 1983 |
Inhibition of male fertility by STS 557.
Topics: Animals; Contraceptives, Oral, Combined; Fertility; Fructose; Gonadotropins; Levonorgestrel; Male; Nandrolone; Norgestrel; Rabbits; Reproduction; Semen; Sialic Acids; Sperm Motility; Testosterone | 1983 |
Pharmacological activities of the progestin STS 557.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Body Temperature; Contraceptives, Oral, Combined; Dogs; Drinking; Eating; Guinea Pigs; Hemodynamics; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Muscle, Smooth; Nandrolone; Norgestrel; Progesterone Congeners; Rats | 1983 |
Data on acute toxicity of the progestin STS 557.
Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity | 1983 |
Long term toxicological studies on the progestin STS 557.
Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors | 1983 |
STS 557 as an interceptive in baboons.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Levonorgestrel; Menstruation; Nandrolone; Norgestrel; Papio; Progesterone; Progesterone Congeners | 1983 |
Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
Topics: Absorption; Adult; Contraceptive Agents; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Ovulation; Progesterone; Vagina | 1983 |
Contraception with levonorgestrel-releasing subdermal capsules, Norplant, after pregnancy termination.
Topics: Abortion, Induced; Adolescent; Adult; Blood Pressure; Capsules; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Pregnancy | 1983 |
Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
Topics: Capsules; Contraceptives, Oral, Combined; Dimethylpolysiloxanes; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Silicones | 1983 |
Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
Topics: Adult; Contraceptives, Oral, Combined; Endometrium; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel; Ovary; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone; Vagina | 1983 |
The effect of cotrimoxazole on oral contraceptive steroids in women.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy, Tubal | 1983 |
Influence of acetaminophen-induced hepatic necrosis on the pharmacokinetics of levonorgestrel.
Topics: Acetaminophen; Animals; Biological Availability; Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Combined; Female; Kinetics; Levonorgestrel; Mice; Norgestrel; Radioimmunoassay; Stereoisomerism | 1983 |
Influence of a levonorgestrel-containing contraceptive vaginal ring on plasma lipids and lipoproteins in cynomolgus monkeys.
Topics: Animals; Cholesterol; Cholesterol, HDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Female; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Macaca fascicularis; Norgestrel; Triglycerides | 1983 |
User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic.
Topics: Adolescent; Adult; Brazil; Contraception Behavior; Contraceptive Agents, Female; Contraceptive Devices; Contraceptives, Oral; Contraceptives, Oral, Combined; Dominican Republic; Estradiol; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Norgestrel; Silicone Elastomers; Surveys and Questionnaires | 1983 |
Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
Topics: Adult; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Insulin; Levonorgestrel; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; Norgestrel; Pilot Projects | 1983 |
[Residual ovarian function after minidoses of estroprogestative agents].
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Ovary | 1983 |
Long-acting contraceptive agents: levonorgestrel esters of unsaturated acids.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Fatty Acids, Unsaturated; Indicators and Reagents; Levonorgestrel; Magnetic Resonance Spectroscopy; Norgestrel; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: aliphatic and alicyclic carboxylic esters of levonorgestrel.
Topics: Carboxylic Acids; Contraceptives, Oral; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Indicators and Reagents; Levonorgestrel; Norgestrel; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: analysis and purification of steroid esters.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Indicators and Reagents; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel.
Topics: Animals; Chromatography, Gas; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Hydrolysis; Levonorgestrel; Liver; Norethindrone; Norgestrel; Rabbits; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters.
Topics: Animals; Biological Assay; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Estrus; Female; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1983 |
Levonorgestrel as a new radioligand for determination of sex hormone binding globulin in human plasma.
Topics: Contraceptives, Oral, Combined; Dihydrotestosterone; Female; Humans; Kinetics; Levonorgestrel; Ligands; Male; Norgestrel; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Sex Factors; Sex Hormone-Binding Globulin; Stereoisomerism; Tritium | 1983 |
Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstruation; Norgestrel; Ovary | 1984 |
Plasma lipoproteins and fatty acid composition after "minipill".
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Norgestrel; Triglycerides | 1983 |
Lipoprotein levels during hormone replacement therapy by vaginal ring pessaries.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Pessaries | 1984 |
Prolactin plasma levels and oral contraceptives at low dosage.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prolactin; Smoking | 1983 |
The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Topics: Adult; Blood Coagulation Factors; Blood Glucose; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Time Factors; Triglycerides | 1983 |
Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climacteric women: effect of oestrogen-progestogen therapy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Climacteric; Contraceptives, Oral, Combined; Drug Therapy, Combination; Epoprostenol; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norgestrel; Thromboxane A2; Thromboxanes | 1984 |
The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat.
Topics: Animals; Castration; Contraceptives, Oral, Combined; Danazol; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Models, Biological; Norgestrel; Peritoneal Cavity; Pregnadienes; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device.
Topics: Adult; Cervix Uteri; Contraceptives, Oral, Combined; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovary; Pituitary Gland; Progesterone | 1984 |
[Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hemolytic-Uremic Syndrome; Humans; Levonorgestrel; Norgestrel | 1984 |
Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
Topics: Adult; Androgens; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Ovary; Ovulation; Plasma; Progesterone | 1984 |
A two-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Egypt; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Pregnancy, Unwanted; Silicone Elastomers | 1984 |
Plasma levels and progestational activity of levonorgestrel after repeated intravenous and subcutaneous administration in the beagle bitch.
Topics: Animals; Cell Division; Contraceptives, Oral, Combined; Dogs; Endometrium; Estrus; Female; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Norgestrel; Plasma; Pregnancy | 1984 |
Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Patient Compliance; Progesterone | 1984 |
A study of interaction between levonorgestrel and ethanol.
Topics: Animals; Biological Availability; Contraceptives, Oral, Combined; Drug Interactions; Ethanol; Female; Half-Life; Levonorgestrel; Metabolic Clearance Rate; Norgestrel; Rats; Rats, Inbred Strains | 1984 |
Influence of STS 557 on the mitotic activity in the endometrium of ovariectomized mice and comparison with the effects of progesterone and levonorgestrel.
Topics: Animals; Castration; Contraceptives, Oral; Contraceptives, Oral, Combined; Endometrium; Female; Levonorgestrel; Mice; Mitosis; Nandrolone; Norgestrel; Progesterone | 1984 |
Effect of a new contraceptive ring releasing 20 micrograms levonorgestrel daily on blood lipid levels and glucose tolerance.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Glucose Tolerance Test; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Phospholipids; Stereoisomerism; Triglycerides | 1984 |
Pharmacokinetics of levonorgestrel in the rat.
Topics: Animals; Contraceptives, Oral, Combined; Cross Reactions; Half-Life; Humans; Immune Sera; Kinetics; Levonorgestrel; Models, Biological; Norgestrel; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains; Species Specificity; Stereoisomerism | 1984 |
[Postcoital contraception with steroid hormones].
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Danazol; Embryo Implantation; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnadienes; Pregnancy; Risk | 1984 |
[Experiences with levonorgestrel in postcoital contraception].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Administration Schedule; Embryo Implantation; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstruation; Norgestrel; Pregnancy; Risk | 1984 |
Hypotriglyceridemic effects of levonorgestrel in rats.
Topics: Animals; Cholesterol; Contraceptives, Oral, Combined; Dimethyl Sulfoxide; Female; Glycerol; In Vitro Techniques; Levonorgestrel; Lipoproteins, VLDL; Liver; Norgestrel; Palmitates; Rats; Rats, Inbred Strains; Triglycerides | 1984 |
Vitamin metabolism and the effects of multivitamin supplementation in oral contraceptive users.
Topics: Adult; Avitaminosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Risk; Thailand; Vitamins | 1984 |
Growth and sexual development before and after sex steroid therapy in patients with thalassemia major.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Growth; Humans; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Progesterone; Puberty; Sexual Maturation; Thalassemia | 1984 |
Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
Topics: Adult; Chloroquine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Primaquine | 1984 |
Hormonal changes during the first year of use of subdermal levonoregestrel implants, Norplant.
Topics: Adult; Contraceptives, Oral, Combined; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Progesterone; Prolactin | 1984 |
Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
Topics: Adult; Bile Acids and Salts; Bilirubin; Ceruloplasmin; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Liver; Liver Function Tests; Norgestrel; Serum Albumin | 1984 |
Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Triglycerides | 1984 |
Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel | 1984 |
Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
Topics: Abortion, Induced; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Fertility; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Pregnancy; Progesterone | 1984 |
Species differences in levonorgestrel binding to serum proteins of monkey, rabbit and rat blood.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Combined; Female; Levonorgestrel; Macaca mulatta; Norgestrel; Rabbits; Rats; Species Specificity; Tritium | 1984 |
Effect of dose on the pharmacokinetics of levonorgestrel in the rat during the rapid elimination phase following subcutaneous administration.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Kinetics; Levonorgestrel; Metabolic Clearance Rate; Norgestrel; Radioimmunoassay; Rats; Rats, Inbred Strains | 1984 |
Changes in urinary homocysteine following synthetic steroidal estrogen and progestogen administration to rats.
Topics: Animals; Chromatography, Thin Layer; Drug Interactions; Ethinyl Estradiol; Female; Homocysteine; Kinetics; Levonorgestrel; Norgestrel; Rats; Rats, Inbred Strains; Stereoisomerism | 1984 |
[Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases].
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Statistics as Topic; Vagina | 1981 |
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism | 1981 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.
Topics: Adult; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteal Phase; Luteinizing Hormone; Menstruation; Norgestrel; Ovulation; Progesterone | 1980 |
Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Menstruation; Norgestrel; Ovulation; Progesterone | 1980 |
Binding of the contraceptive steroids norgestrel and norethisterone in human plasma.
Topics: Binding Sites; Binding, Competitive; Blood Proteins; Dihydrotestosterone; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin; Stereoisomerism; Testosterone | 1980 |
Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Topics: Endometrium; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Menstruation; Microscopy, Electron, Scanning; Norgestrel | 1980 |
Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Dimethylpolysiloxanes; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Progesterone | 1980 |
Effects of levonorgestrel and STS 557 on testis in rodents.
Topics: Animals; Castration; DNA; Female; Fertility; Levonorgestrel; Libido; Luteinizing Hormone; Male; Nandrolone; Norgestrel; Organ Size; Pregnancy; Rats; Sexual Maturation; Testis | 1980 |
The ultrastructural features of progestagen-induced decidual cells in the rhesus monkey (Macaca mulatta).
Topics: Animals; Cervix Uteri; Contraceptive Devices, Female; Decidua; Endometrium; Female; Levonorgestrel; Macaca mulatta; Norgestrel; Ovary; Stereoisomerism; Vagina | 1980 |
Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel.
Topics: Adult; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Vagina | 1981 |
Menstrual blood loss with contraceptive subdermal levonorgestrel implants.
Topics: Adult; Blood Specimen Collection; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Silicone Elastomers; Uterine Hemorrhage | 1981 |
The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa.
Topics: Adult; Ethinyl Estradiol; Female; Humans; Intestinal Mucosa; Jejunum; Levonorgestrel; Male; Mestranol; Middle Aged; Norgestrel | 1981 |
Elevated prolactin levels in oral contraceptive pill-related hypertension.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Norgestrel; Prolactin | 1981 |
Plasma levels of levonorgestrel in women during longterm use of norplant.
Topics: Female; Follow-Up Studies; Humans; Kinetics; Levonorgestrel; Norgestrel; Radioimmunoassay | 1981 |
The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette.
Topics: Adult; Biological Availability; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Radioimmunoassay | 1981 |
Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment.
Topics: Cholesterol; Cholesterol, HDL; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins, HDL; Liver; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel; Stereoisomerism | 1981 |
Zinc and copper nutriture of women taking oral contraceptive agents.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Ethinyl Estradiol; Female; Hair; Humans; Levonorgestrel; Norgestrel; Stereoisomerism; Time Factors; Zinc | 1981 |
[Comparative study of menstrual blood loss with progestagen-releasing intrauterine devices].
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Progesterone | 1981 |
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture.
Topics: Breast Neoplasms; Cell Division; Cell Line; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Levonorgestrel; Norgestrel; Progesterone; Receptors, Progesterone; Tamoxifen | 1981 |
Intracervical release of levonorgestrel for contraception.
Topics: Adult; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Stereoisomerism | 1981 |
Effect of food restriction (undernutrition) on pharmacokinetics of levonorgestrel in rabbits.
Topics: Animals; Female; Hemoglobins; Kinetics; Levonorgestrel; Norgestrel; Nutrition Disorders; Rabbits; Serum Albumin; Stereoisomerism | 1981 |
Oral contraception and breast pathology.
Topics: Adenofibroma; Adenoma; Adult; Animals; Breast Feeding; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estradiol Congeners; Female; Fibrocystic Breast Disease; Humans; Levonorgestrel; Menarche; Middle Aged; Norgestrel; Parity; Pregnancy; Progesterone Congeners; Retrospective Studies; Stereoisomerism | 1981 |
Binding of the gestagens norethisterone and levonorgestrel in blood of various species.
Topics: Animals; Blood Proteins; Dialysis; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Papio; Protein Binding; Rabbits; Rats; Species Specificity | 1981 |
The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Erythrocytes; Ethinyl Estradiol; Female; Glutathione Peroxidase; Humans; Levonorgestrel; Norgestrel; Peroxidases; Pyridoxal; Riboflavin; Selenium; Time Factors | 1981 |
[Triquilar/Trinordiol. A new pill with 3 sequences].
Topics: Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel | 1981 |
Levonorgestrel and estradiol release from an improved contraceptive vaginal ring.
Topics: Contraceptive Devices, Female; Delayed-Action Preparations; Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Norgestrel; Vagina | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Vagina | 1981 |
Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. I. Carbohydrate metabolism and liver function.
Topics: Blood Glucose; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Liver; Liver Function Tests; Norgestrel; Prospective Studies; Vagina | 1981 |
The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptive Devices, Female; Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Norgestrel; Triglycerides; Vagina | 1981 |
Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Norgestrel; Prospective Studies; Vagina | 1981 |
Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring.
Topics: Adolescent; Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Diet; Dominican Republic; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Norgestrel; Triglycerides; Vagina | 1981 |
The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora.
Topics: Adult; Candida; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Levonorgestrel; Neisseria gonorrhoeae; Norgestrel; Vagina | 1981 |
[Chromosomal analysis of baboons and their mothers, following application to mothers of potentially post-ovulation fertility-inhibiting steroids (author's transl)].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Chromosome Mapping; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Levonorgestrel; Lymphocytes; Nandrolone; Norgestrel; Papio; Pregnancy | 1981 |
Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.
Topics: Breast Feeding; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Milk, Human; Norgestrel; Stereoisomerism | 1982 |
Serum bile acids during biphasic contraceptive treatment with ethinyl estradiol and norgestrel.
Topics: Adolescent; Adult; Bile Acids and Salts; Cholic Acid; Cholic Acids; Contraceptives, Oral; Contraceptives, Oral, Combined; Deoxycholic Acid; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Function Tests; Norgestrel; Stereoisomerism | 1982 |
The value of endometrial cell sampling in the management of post-menopausal women.
Topics: Cytodiagnosis; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Menopause; Norgestrel; Polyps; Stereoisomerism; Uterine Neoplasms | 1981 |
Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Longitudinal Studies; Norgestrel | 1982 |
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies | 1982 |
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effects of progestogens on the cardiovascular system.
Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins | 1982 |
Effects of oestradiol and levonorgestrel on lipoprotein lipids and postheparin plasma lipase activities in normolipoproteinaemic women.
Topics: Adult; Cholesterol; Estradiol; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoprotein Lipase; Lipoproteins; Liver; Middle Aged; Norgestrel; Triglycerides | 1982 |
Fertility after discontinuation of levonorgestrel-releasing intrauterine devices.
Topics: Adult; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism; Time Factors | 1982 |
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adolescent; Adult; Amenorrhea; Apgar Score; Breast Feeding; Female; Humans; Infant, Newborn; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Male; Norgestrel; Otitis Media; Postpartum Period; Pregnancy; Respiratory Tract Infections; Sex Ratio | 1982 |
Low dosage oral contraception in women with previous gestational diabetes.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prospective Studies | 1982 |
Ultrastructure of cervical mucus and sperm penetration during use of a triphasic oral contraceptive.
Topics: Cervix Mucus; Contraceptives, Oral; Contraceptives, Oral, Sequential; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Male; Microscopy, Electron, Scanning; Norgestrel; Sperm Motility | 1982 |
Toxicity of the progestagen STS 557 compared to levonorgestrel in beagles after oral administration for 6 months.
Topics: 11-Hydroxycorticosteroids; Administration, Oral; Animals; Dogs; Female; Levonorgestrel; Male; Nandrolone; Norgestrel; Progesterone Congeners; Time Factors | 1982 |
The effects of ampicillin on oral contraceptive steroids in women.
Topics: Adult; Ampicillin; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Norethindrone; Norgestrel; Progesterone; Time Factors | 1982 |
Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
Topics: Adult; Brain Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Topics: Adult; Blood Pressure; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
The effect of levonorgestrel and estrone rods on male reproductive function.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Synergism; Estrone; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Sperm Count; Spermatogenesis; Testosterone | 1982 |
Ovulation suppression in women following vaginal administration of oral contraceptive tablets.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Vagina | 1982 |
Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovary; Ovulation; Random Allocation; Sex Hormone-Binding Globulin | 1982 |
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Topics: Adult; Blood Glucose; Castration; Contraceptives, Oral, Combined; Female; Glucose Tolerance Test; Humans; Hysterectomy; Insulin; Levonorgestrel; Lipids; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Neoplasms | 1982 |
Further report on the interceptive STS 557 in baboons.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Female; Levonorgestrel; Nandrolone; Norgestrel; Papio; Pregnancy; Progesterone | 1982 |
[Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Estrus; Female; Levonorgestrel; Long-Term Care; Menstruation; Nandrolone; Norgestrel; Pregnancy; Vaginal Smears | 1982 |
Effects of oestradiol on sex hormone binding globulin.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Female; Humans; Levonorgestrel; Menopause; Menotropins; Menstruation; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1982 |
Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Corpus Luteum; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Time Factors | 1982 |
Hormone replacement therapy and sexuality in women.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hysterectomy; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Sexual Behavior | 1982 |
The effect of ethinyl estradiol 20 mcg and levonorgestrel 250 mcg on the pituitary-ovarian function during normal tablet-taking and when tablets are missed.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Menstruation; Norgestrel; Ovary; Pituitary Gland; Progesterone | 1982 |
Serial detection of plasma-factor XIII levels during the ovulatory cycle and estroprogestative contraception.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor XIII; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Ovulation | 1982 |
Immediate postabortal insertion of a levonorgestrel-releasing IUD.
Topics: Abortion, Legal; Adolescent; Adult; Chorionic Gonadotropin; Contraceptives, Oral, Combined; Estradiol; Evaluation Studies as Topic; Female; Follicle Stimulating Hormone; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Luteinizing Hormone; Menstruation; Norgestrel; Ovulation; Pregnancy; Progesterone | 1982 |
[Effects of hormonal contraception on benign changes of the breast].
Topics: Adenofibroma; Adenoma; Adult; Breast Diseases; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cysts; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1982 |
[Clinical evaluation of 1,668 cycles of triphasic oral contraception (Trigynon). Multicentric Belgian study].
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1982 |
Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glycoproteins; Humans; Immunoassay; Levonorgestrel; Menstruation; Norgestrel; Proteins | 1982 |
Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device.
Topics: Amenorrhea; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Erythrocyte Count; Erythrocyte Indices; Female; Ferritins; Hematocrit; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norgestrel; Postpartum Period; Pregnancy | 1982 |
[Premenstrual tension syndrome: current pathophysiologic and therapeutic concepts].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Premenstrual Syndrome | 1982 |
Serum lipoprotein and apolipoprotein changes during treatment with a contraceptive vaginal ring containing levonorgestrel and estradiol.
Topics: Adult; Apolipoproteins; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Triglycerides | 1982 |
Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.
Topics: Adipose Tissue; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Endometrium; Fallopian Tubes; Female; Humans; In Vitro Techniques; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Myometrium; Norgestrel | 1982 |
Hormonal consequences of "missing the pill".
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Progesterone; Progesterone Congeners; Progesterone-Binding Globulin; Time Factors | 1982 |
Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Progesterone Congeners; Time Factors; Uterine Hemorrhage; Vagina | 1982 |
Norethisterone-4 beta,5-oxide and laevonorgestrel-4 beta,5-oxide: formation in rat liver microsomal incubations and interference with microsomal epoxide hydrolase and cytoplasmic glutathione S-transferase.
Topics: Animals; Chromatography, Thin Layer; Cytoplasm; Epoxide Hydrolases; Glutathione Transferase; In Vitro Techniques; Levonorgestrel; Male; Mass Spectrometry; Microsomes, Liver; Mutagenicity Tests; Norethindrone; Norgestrel; Rats | 1981 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
A non-human primate study (baboon; Papio hamadryas) to determine if a long-acting progestogen, levonorgestrel butanoate, combined with a long-acting androgen, testosterone buciclate, can suppress spermatogenesis: I. Dose-finding study.
Topics: Adrenal Cortex Hormones; Animals; Dose-Response Relationship, Drug; Gonadotropins; Levonorgestrel; Male; Norgestrel; Papio; Sperm Count; Spermatogenesis; Testosterone | 1995 |
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis | 1995 |
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat.
Topics: Androgens; Animals; Female; Kinetics; Levonorgestrel; Male; Norgestrel; Orchiectomy; Organ Size; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Prostate; Rats; Seminal Vesicles | 1994 |
Biomembrane permeation and stereochemistry.
Topics: Animals; Cell Membrane Permeability; Humans; In Vitro Techniques; Levonorgestrel; Mathematical Computing; Mucous Membrane; Norgestrel; Rabbits; Skin Absorption; Stereoisomerism | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Nausea; Norgestrel; Vomiting | 1996 |
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism | 1997 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Stability; Female; Humans; Levonorgestrel; Mass Spectrometry; Molecular Structure; Norgestrel; Oximes; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Faculty of Family Planning and Reproductive Health Care. Royal College of Obstetricians and Gynaecologists. Guidance April 2000. Emergency contraception: recommendations for clinical practice.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pregnancy | 2000 |
Ortho Evra--a contraceptive patch.
Topics: Contraceptive Agents; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
[Postcoital contraception].
Topics: Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Delivery of Health Care; Developed Countries; Ethinyl Estradiol; Europe; Evaluation Studies as Topic; Family Planning Services; Germany, West; Health; Health Planning; Health Services; Health Services Administration; Hormones; Levonorgestrel; Medicine; Norgestrel; Patient Acceptance of Health Care; Population; Population Dynamics; Program Evaluation; Reproductive Control Agents; Time Factors | 1984 |
[Post-coital contraception].
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Diethylstilbestrol; Disease; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Intrauterine Devices; Levonorgestrel; Norgestrel; Physiology; Pregnancy Complications; Pregnancy, Ectopic; Reproductive Control Agents | 1985 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
[Assessment of selected neoplastic markers in women receiving hormone replacement therapy].
Topics: Biomarkers, Tumor; Breast Diseases; Carcinoembryonic Antigen; Case-Control Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Middle Aged; Mucin-1; Norgestrel; Peptides; Radioimmunoassay; Time Factors | 2003 |
Bioequivalence study of postcoital emergency contraceptions containing levonorgestrel.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Norgestrel; Therapeutic Equivalency | 2004 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial | 2006 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |
Modelling costs and outcomes of expanded availability of emergency contraceptive use in British Columbia.
Topics: British Columbia; Contraceptives, Postcoital; Cost Savings; Decision Support Techniques; Decision Trees; Drug Utilization; Ethinyl Estradiol; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Levonorgestrel; Norgestrel; Outcome Assessment, Health Care; Pharmaceutical Services; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unwanted | 2007 |
[Emergency contraception ].
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Mifepristone; Norgestrel; Time Factors | 2008 |
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Topics: Adolescent; Adult; Anticoagulants; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Denmark; Drug Implants; Epidemiologic Methods; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Transdermal Patch; Venous Thrombosis; Young Adult | 2012 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Humans; Levonorgestrel; Norgestrel; Oximes | 2015 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |
Synergistic effects of EP-1 and ivermectin mixture (iEP-1) to control rodents and their ectoparasites.
Topics: Animals; Drug Combinations; Female; Flea Infestations; Ivermectin; Levonorgestrel; Male; Mice; Norgestrel; Quinestrol; Rodentia; Siphonaptera; Ticks | 2023 |